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ABSTRACT
Background: Laryngeal mask airway (LMA) is a common airway device used intraoperatively for
anesthetic airway management. The insertion of LMA requires anesthesia and adequate suppression of
airway reflexes. The factors that affect the insertion and positioning of LMA are jaw relaxation, mouth
opening, episodes of coughing or movement during insertion, and the depth of anesthesia. If all these
parameters are satisfactory, then there will be a minimal hemodynamic stress response, which is required
for LMA insertion. In search of an optimum drug, recent studies have suggested that dexmedetomidine is
superior to fentanyl as an anesthetic adjuvant in decreasing the requirement of propofol and maintaining
stable hemodynamics intraoperatively.
Objectives: This literature review aimed to evaluate the current randomized controlled trials (RCTs) on
the impact of dexmedetomidine as an adjunct to propofol during LMA insertion.
Data sources: Data sources included MedLine, CINAHL, EMBASE, Pubmed, and Google Scholar.
Sources were chosen to answer the Population, Intervention, Comparison, and Outcome (PICO) question:
(P) In adult surgical patients who present for laryngeal mask insertion (I), does DexmedetomidinePropofol IV (C) compared to Fentanyl- Propofol IV (O) decrease hemodynamic instability, ensure
spontaneous respirations, and reduce the propofol dosage requirement for induction?
Study selection: The inclusion criteria for the articles included: Studies published after 2019, RCTs
published in English, dexmedetomidine as the treatment, and opioid consumption as the primary
outcome. Exclusion criteria included: meta-analyses and systematic analyses, failure to focus on LMA
insertion, and dexmedetomidine not used as treatment.
Results: The evidence search, and screening resulted in 15 RCTs. Eleven studies demonstrated
dexmedetomidine is a superior adjuvant in preserving respirations and a stable hemodynamic profile.
Four studies demonstrated dexmedetomidine could reduce propofol dose requirements by as much as
38%.
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Conclusion: Evidence shows that dexmedetomidine as a co- induction agent with propofol not only
gives excellent overall insertion conditions and hemodynamic stability but also reduces the requirement
of induction as well as incremental doses of propofol.
Keywords: Dexmedetomidine, LMA, fentanyl, surgical units, surgery, postoperative, perioperative.
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BACKGROUND
Introduction
Maintaining a patent airway remains a significant concern to anesthesia providers. Dr. Archibald
Brain invented the "Laryngeal Mask Airway" (LMA) in 1981 as an alternative to an endotracheal tube.4
The LMA is a supraglottic airway device that secures the airway, allowing spontaneous ventilation.8 The
lighter plane of anesthesia required for LMA insertion has the potential to provide excellent
hemodynamic stability, which makes its use very attractive to anesthesia providers. However, proper
anesthetic depth is necessary to allow attenuation of upper airway reflexes to avoid coughing, gagging,
and laryngospasm.10
Numerous studies focus on finding the ideal balance of anesthesia to provide optimum sedation
for LMA insertion. Due to its rapid induction and recovery time, intravenous propofol has been the drug
of choice to produce sedation and hypnosis.1 The cardio-respiratory effect when using propofol alone has
been a well-known concern for anesthesia.10 There is also a lack of analgesic effect from propofol. To
avoid these complications, fentanyl was added to reduce propofol dose requirements and provide
analgesic properties. Unfortunately, the lack of spontaneous breathing and the frequency of lasting apneic
episodes makes the use of fentanyl not favorable. Dexmedetomidine properties show to be beneficial for
sedation and analgesia without resulting in cardio-respiratory depression.10 Therefore, dexmedetomidine
continues to be the focus of this Quality Improvement Project for propofol adjuncts during LMA
insertion.
Clinical Significance
The laryngeal mask airway is proven to be a safe and effective method to secure an airway that
improves hemodynamic stability through the three phases of anesthesia.1 LMA allows pressure support
ventilation with airway pressures not exceeding 15 cm H2O.10 Cardiovascular variables are a major
concern during the induction and maintenance of anesthesia. Reports suggest the use of propofol alone
has been reported to be inadequate for LMA insertion, given it could require higher doses for proper
insertion but increasing the risk of hemodynamic and respiratory instability, also described as unethical.10
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The use of propofol alone has been reported to require a higher dosage, such as 2.5 mg/ kg, for
appropriate LMA insertion. 10 There are reports suggesting a smaller dosage of propofol when used in
combination with dexmedetomidine (1.5 mg/kg) compared to Fentanyl (1.8 mg/kg). 8
Opioids such as fentanyl have been the adjunct of choice to inhibit the sympathetic response
associated with LMA placement. Fentanyl provides homeostasis of the cardiovascular system through
action on the nucleus solitarius, nucleus ambiguous, dorsal nucleus of the vagus, and the parabrachial
nucleus.10 The effect of fentanyl through mu2 receptors acts as a potent respiratory depressant.10 When
combined with propofol, fentanyl causes respiratory compromise by inhibiting carbon dioxide's stimulatory
effects, leading to apnea

10

. Glottic rigidity has been described after repeated doses of fentanyl.9

Hemodynamic instability was reported by Gupta et al. after fentanyl administration, resulting in an
increased heart rate up to 10% and a rise in systolic blood pressure at the 1st and 3rd minute after LMA
insertion. Gupta et al. found in study participants that received dexmedetomidine, 58 patients had
spontaneous respirations while 12 exhibited breath-holding. While in a group that received fentanyl, 36
patients maintained spontaneous respirations and 34 patients showed breath-holding. The difference was
found to be statistically significant.
Dexmedetomidine properties provide sedation and analgesia via the α2- adrenoceptor in blood
vessels, sympathetic terminals, locus coeruleus, and spinal cord.9 Dexmedetomidine action on the locus
coeruleus preserves hypercapnic ventilatory drive, and this effect gives the appearance of natural sleep.10
An increase in respiratory rate during dexmedetomidine infusions is secondary to its mechanism of action
not only on the locus coeruleus but also in the pulmonary vasculature and carotid body by stimulating the
respiratory center.9 The cardiovascular stabilizing properties and preservation of spontaneous respiration of
dexmedetomidine are ideal for reducing propofol requirements and attenuation of sympathetic response
during LMA insertion.8 Studies have shown that dexmedetomidine has anesthetic and analgesic properties
and at dosages of 0.5mcg-2mcg /kg/IV causes sedation. Dexmedetomidine can decrease the heart rate by
27% during induction but return to normal at 15 min.4
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Jayaram et al. reported 69% of apnea in the propofol-fentanyl group compared to 40% in the
propofol- dexmedetomidine group. Significant lower systolic, diastolic blood pressure, and mean arterial
pressure in the propofol-fentanyl group compared to the propofol-dexmedetomidine was also reported.
When compared to dexmedetomidine, fentanyl has not only been found to suppress respiratory drive but
also is associated with nausea and vomiting.10 The use of fentanyl could imply the need for additional
medication to control the side effects of nausea and vomiting. Even apneic episodes related to the use of
dexmedetomidine may be due to a higher dose of propofol (2.5mg/kg) when used in combination.9
The use of dexmedetomidine infusion has been reported to delay emergence time; nonetheless,
spontaneous breathing and oxygen saturation were well preserved in all patients.9 The use of fentanyl has
been felt to potentiate the depressant effect from propofol, therefore causing longer apneic episodes.
Postoperative pain evaluation is of great clinical relevance after emergence time. Pain score tools have
been validated to assess a patient's pain level during the recovery period; one validated score is the visual
analog score (VAS).9 Choudhary et al. demonstrated significantly lower VAS values in the postoperative
pain management for the patient that received dexmedetomidine compared to fentanyl. Overall,
dexmedetomidine is found to be unique among other sedatives given its clinical safety regarding
respirations even with high doses enough to cause significant central nervous system depression with
LMA placement stimulation in the hypopharynx.
There is not sufficient data to address the clinical outcome as well as the cost related to the use of
dexmedetomidine over fentanyl. One can imply the postoperative recovery would be faster with
dexmedetomidine compared to fentanyl with less requirement for adjunctive symptomatic management
such as pain control, nausea, vomiting, but this is not well studied. Fentanyl will carry a higher liability
within institutional administrative logistics such as storage, documentation, and distribution of opioids
compared to dexmedetomidine; there are also higher concerns of possible drug abuse with the use of
fentanyl compared with dexmedetomidine.10
PICO Question
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The following PICO was formulated: (P) In adult surgical patients who present for laryngeal
mask insertion (I), does an educational module on Dexmedetomidine- Propofol IV increase knowledge
(C) compared to Fentanyl- Propofol IV (O) decrease hemodynamic instability, ensure spontaneous
respirations, and reduce the propofol dosage requirement for induction?
METHODOLOGY
Information Sources and Search Strategy
A literature search was conducted to identify studies on patients receiving propofol and fentanyl or
propofol and dexmedetomidine while undergoing laryngeal mask airway (LMA) insertion. Evidence
selection requires the selection of credible databases and sources. Many databases are available with a wide
range of articles in different fields of healthcare provisions. The initial search utilized the following
databases: Cochrane Database of Systematic Reviews, Medline (ProQuest), Cumulative Index of Nursing
and Allied Health Literature (CINAHL), Scopus, Google Scholar, and PubMed. For this Quality
Improvement Project, CINAHL was the primary database for the identification of relevant sources.
CINAHL had many articles with pertinent information, including clinical interventions, for addressing
various clinical problems. 1
The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) was utilized
to enhance the objectivity of the search and formatting of the systematic review.1In this context; the
methodological approach employed the PRISMA checklist to ensure the creation of credible evidence for
clinicians. The reliability of the systematic review is dependent on the previous studies, the clarity of
documentation, and research processes.
The formulated PICO question was used in developing keywords and concepts to aid in the
identification of relevant sources within the selected databases.4 The search terminology included the
efficacy of dexmedetomidine combined with propofol in LMA insertion, the effectiveness of fentanyl in
combination with propofol for LMA, dexmedetomidine as an alternative to fentanyl when co-administered
with propofol, hemodynamic stability of fentanyl versus dexmedetomidine, dexmedetomidine versus
fentanyl in preserving respiration. 1 The PRISMA flow diagram outlines the search and screening process
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as illustrated in fig. 1. The search was conducted in October 2020; thus, the search was current and up to
date. The selected databases resulted in a different number of articles related to the search terminologies.
PubMed yielded 98 articles, Medline resulted in 112 articles, and CINAHL revealed 143, and Scopus
resulted in 56 results. A total of 409 articles were retrieved from the selected databases. Duplicated articles
were removed, leaving 204 articles for further evaluation.
The credibility of the selected sources and databases generated substantial evidence associated with
the adoption of clinical interventions identified in the formulated PICO question.4 Reliable sources are
current and up to data reflecting interventions in the management of the selected clinical problem. Most
significantly, credible sources tend to focus on a particular area or audience .3 Authority of the authors are
some of the aspects of criteria when evaluating articles in the databases. Credible sources evaluate a
relatively large quantity of preliminary studies to draw significant findings and conclusions of the study. In
this literature review, the identified journal articles met such criteria.4
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Records identified
through database
searching
(n = 409)

Additional records
identified through other
sources
(n = 0)

Screening

Records after duplicates removed
(n =204)

Records screened
(n = 204)

Included

Eligibility

Full-text articles assessed
for eligibility
(n = 23)

Studies included in
qualitative
synthesis
(n = 15)

Figure 1. PRISMA Flow Diagram
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Study Selection and Screening Method: Inclusion/Exclusion Criteria
The formulated PICO question was useful in evaluating the appropriate articles, including the
dissemination of the selected articles. The search strategy also determined the levels of evidence in the
hierarchy of evidence of scientific sources. Citations were imported to Endnote to check for duplicated
articles. The screening of the 15 articles was based on sets of inclusion and exclusion criteria.
Inclusion Criteria
The inclusion criteria for the selection of the article include the following.
•

Publications in the English language were selected in the proposed research investigation.

•

References published within the last ten years (2010-2020).

•

Sources considered from the databases must be relevant to the selected topic.

Other inclusion criteria include selecting observational studies, case-control: cohort studies, and
randomized control trials (RCTs). The studies included surgical patients taking Dexmedetomidinepropofol combination IV or Fentanyl-propofol IV for laryngeal mask insertion. Other critical information
forming part of the evaluation criteria include dosage requirements for LMA insertion, cardio-respiratory
stability, and decreased narcotic utilization.
Exclusion Criteria
The exclusion criteria consisted of patients mainly using dexmedetomidine and fentanyl as single
therapies for pain management following the intraoperative and postoperative period. Inclusion and
exclusion criteria are illustrated in table 1 below.
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Table 1. Inclusion and Exclusion Criteria
Inclusion
Exclusion
Population:
Population:
• Intervention group use combination suggested
• Non-surgical patients on
Medications.
either treatment regimen.
• Adult surgical patients who present for laryngeal
• Surgical patients ventilated
mask insertion who received
with an endotracheal tube.
Dexemedetomidine- Propofol IV
• Patients receiving either
compared to Fentanyl- Propofol IV
medication in the
Intervention
postoperative period for
pain control
• Studies that investigate the effect of
dexmedetomidine-propofol combination IV or Intervention:
Fentanyl-propofol IV for facilitating successful
• Sedations effects of either
laryngeal mask airway (LMA) insertion.
medication in patients that
Outcomes:
remained mechanically
• Decrease hemodynamic instability in a patient
ventilated.
treated with dexmedetomidine and propofol
Outcomes:
versus fentanyl and propofol
• Interventions other than
• Preservation of spontaneous respirations in a
patients that received LMA
patient treated with dexmedetomidine
and were induced with
fentanyl or
• Reduction of propofol dosage requirement for
dexmedetomidine.
induction
Type of study:
Type of study:
• Publication date pre-2010
• Inclusion of observational studies, case-control,
cohort, and RCTs.
• Dissertations/theses
• Questionnaire
• Animal studies

Collection, Analysis, and Data Items
John Hopkins' rating structure is critical in evaluating research studies and has five levels of evidence
in assessing the reliability of the research study. RCTs and systematic reviews provide the highest level of
evidence (level 1). In this literature search, RCTs and observational studies were selected. Level 2 evidence
includes articles, whereas quasi-experimental studies and non-experimental studies, including expert
opinions, are level 4. Most significantly, level 5 provides clinician experience, clinical case reports, and
literature reviews. According to the John Hopkins tool, evidence can be described as bad, good, or low
quality based on the position of the evidence on the hierarchy of evidence. 5 High-quality evidence describes
data that is reliable, large sample size, definitive conclusions, and evaluation of the outcomes.5 Low- or
poor-quality evidence is associated with relatively small sample size and unclear findings and conclusions
of the study.5
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An evaluation table was developed to summarize and categorize aspects of the studies included
for this systematic review, see table 2. The individual studies were assigned rankings based on the John
Hopkins evaluation tool.1 The evaluation table contains highlights of the author, publication date, results,
and the levels of evidence-based on the Johns Hopkins Research Evidence evaluation tool.

Table 2. Studies Included in the Appraisal
Indication in Study
Influence of
the use of
type/
dexmedetomi
Author
dexmedetomi Sample
dine vs.
(Year) &
dine vs.
size
fentanyl on
Level of
fentanyl in
hemodynami
Evidence
anesthesia
cs during
insertion
Subhadra
lower
Randomi The
et al.
abdominal
zed
reductions in
(2014)
and lower
singleSBP, DBP,
limb surgery
center
MAP was
Level 2
patients
study/60
greater in
Quality B
patients
Group with
Fentanyl
Ramaswam Elective
Prospecti Hemodynami
y et al.
minor surgical ve,
cs were stable
(2015)
procedures
doublein both groups
blind,
Level 2
randomiz
Quality B
ed
study/80
patients

Insertion
conditions (Muzzi
score)

Successful
induction in
relation to
apneic
episodes

Guidelines
provided

Better
hemodynamics
during insertion
with
dexmedetomidine

More apnea in
the Fentanyl
group

Increase in the RR
in the
dexmedetomidine
Group from 5 min
after insertion

duration of
apnea was
longer in the
Fentanyl
Group (290 s)
than in the
dexmedetomi
dine Group
(227 s).

Suggested
dexmedetomi
dine similar to
fentanyl,
although left
hemodynamic
concerns
Suggest that
Dexmedetomi
dine can be a
comparable
alternative to
fentanyl
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Choudhary
et al.
(2019)
Level 1
Quality A

Elective urosurgical
procedures
lasting <120
min

Prospecti
ve,
randomiz
ed,
doubleblinded,
parallelgroup
clinical
trial/74
patients

Hemodynami
cs were stable
in both groups

insertion score in
six patients was >2,
and in the PD
group, three
patients had score
>2 (Not significant)

Incidence of
apnea was
greater in the
Fentanyl
group

Dexmedetomi
dine preserved
the patient's
spontaneous
breathing and
provided
better
postoperative
analgesia.

SBP had
highly
significant
differences at
1, 3, 5, 10,
and 15 mins.
DBP, MAP
and RR had
highly
substantial
differences at
1, 3, 5, 10, 15,
and 30 mins
No difference
in
hemodynamic
s

Better preservation
of spontaneous
respiration and
acceptable LMA
insertion conditions
for
Dexmedetomidine

Apnea was
237 sec in the
Fentanyl
group vs. 208
sec in the
Dexmedetomi
dine

Dexmedetomi
dine better
insertion and
hemodynamic
s, and
acceptable
LMA
insertion.

The induction dose
and increments of
propofol required
in group D was
significantly lower

Apnea
occurred with
both
medications

Dexmedetomi
dine
significantly
reduces
induction dose
propofol for
PLMA
insertion

Sample
Size: 1

Gupta et al.
2018

elective minor
surgical
procedures

Prospecti
ve,
doubleblind,
randomiz
ed
clinical
study/
140
patients

short surgical
procedures

Prospecti
ve
randomiz
ed,
doubleblind
study/60
patients

Level 1
Quality A

Shalaka et
al. 2016
Level 1
Quality A
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Uzümcügil
et al.
(2010)

Minor
urological
procedures

Prospecti
ve
randomiz
ed
study/52
patients

Baseline
systolic BP
(SBP) and
mean BP
(MBP) were
similar

Dexmedetomidine,
before propofol
induction, provides
successful
laryngeal mask
insertion
comparable to
fentanyl

Apnea was
greater in the
Fentanyl
Group

Dexmedetomi
dine preserves
respiratory
functions
better during
induction

short elective
surgeries

A
prospecti
ve,
randomiz
ed,
doubleblind
comparati
ve study.
/60
patients

Better jaw
relaxation in
dexmedetomidine.
More attempts
needed with
Fentanyl

No
significant
changes in
RR

Dexmedetomi
dine gives
better
insertion
conditions and
less pressor
response to
LMA insertion

elective
surgeries

Increased of
the SBP with
the use of
Fentanyl
compared to
Pre LMA
baseline. Fall
in SBP at 1
min, 2 mins,
3mins with
dexmedetomi
dine
compared to
Pre LMA
baseline
no significant
hemodynamic
response
difference

Randomi
zed,
prospecti
ve,
singleblinded,
clinical
study/78
patients
Randomi Non reported
zed,
controlled
trial/75
patients

The first insertion
attempt was equal
for both
medications

Non-reported

TCI
significantly
lowered the
propofol
consumption

high rate of
successful first
attempt at insertion
with 1 μg.kg and
1.5 μg.kg, 93% and
87% respectively,
compared to 87%
in the 2.0 μg.kg-1
group.

Higher doses
of fentanyl
are associated
with an
increased
incidence of
apnea.

Moderately relaxed
jaw during LMA

Incidence and
the mean

Yes,
recommends
1.0 μg.kg as
the optimal
dose of
fentanyl when
used in
addition to
propofol 2.5
mg/kg for
LMA
Dexmedetomi
dine and

Level 2
Quality B

Surabhi et
al.
(2014)
Level 1
Quality A

Sintavanur
uket al.
(2020)
Level 1
Quality

Tan et al.
(2017)

Nonparalyzed
patients.

Level 1
Quality A

Sample
Size: 1

Rustagi et
al.

short surgical
procedures

Randomi
zed

MAP after
propofol
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(2019)

controlled
doubleblinded
study/80
patients

Level 1
Quality B

induction was
significantly
lower with
Fentanyl

Sample
size: 1

Yoo et al.
(2017)

elective minor
surgery

Blind
RCT/40
patients

Elective
unilateral
strabismus
surgery,
children

Randomi
zed,
doubleblind,
placebocontrolled
study/90
patients

Level 1
Quality A

Yao et al.
(2019)
Level 1
Quality A

Joshi et al.
(2013)
Level 1
Quality B

Ambulatory
surgery with
an expected
duration
of less than 2
hours

MAP was
higher, and
HR was lower
in the
dexmedetomi
dine

Intranasal
dexmedetomi
dine (1 or 2
mcg/ kg)
produces a
dosedependent
reduction in
HR and SBP.
Modest
reduction
(within 20%
of baseline
values) of
hemodynamic
variables was
observed
Randomi The
zed,
intraoperative
doublehemodynamic
blinded,
variables (i.e.,
controlled HR and
trial/100
MAP) and
patients
RR, as well as
SpO2 and
ETCO2values
in the two

insertion was
higher in Fentanyl.
None of the
patients had a
poorly relaxed jaw.
More coughing and
movement with
Fentanyl use
The total dose of
propofol was
higher with
fentanyl
Pretreatment with
dexmedetomidine 1
μg/kg could reduce
the propofol
requirement by 38
% for facilitating
LMA insertion
without prolonged
respiratory
depression and
hemodynamic
instability.
No subject cried,
required restraint,
or
complained of
discomfort with
intranasal
dexmedetomidine

duration of
apnea was
significantly
more with
fentanyl

fentanyl
provide
comparable
conditions for
LMA insertion
with propofol.

Respiratory
depression
and
hemodynamic
instability.

A bolus dose
of propofol
needed for
successful
LMA insertion
was 1.9 mg/kg
in 50 % of
adults.
dexmedetomid
ine reduces the
propofol
requirement
Yes,
Dexmedetomi
dine
premedication
was associated
with a
reduction in
sevoflurane

Fentanyl
pretreatment group
had a lower
frequency of
movements.
intraoperative
laryngospasm was
similar

Fentanyl
pretreatment
group had a
higher
frequency of
apnea and a
longer
duration of
manual
ventilation.
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No apnea
reported

Pre induction
fentanyl
increased the
frequency of
apnea at
induction and
duration of
manual
ventilation but
reduced the

18

Dwivedi al.
(2016)

Various
surgical
procedures

Prospecti
ve,
randomiz
ed study

elective
surgery
(modified
radical
mastectomy,
mastectomy,
or superficial
surgery of the
upper limb)

Randomi
zed
doubleblind
study/96
patients

Level 1
Quality B

Akanksha
et al.
(2012)
Level 1
Quality B

groups, were
similar.
After
insertion of
LMA,
statistically
significant
drop-in means
heart rate,
systolic
blood
pressure (BP),
diastolic BP,
and mean BP
was noted in
Group
Fentanyl as
compared to
Group
butorphanol
(P < 0.05).
Significant
fall in SBPs
and MAP, and
higher
incidence of
bradycardia
with fentanyl
use

Propofol, when
used as a sole
drug for LMA
placement requires
a large dose to
achieve
optimal insertion
conditions.

Non-released

Pre-administered
dose of fentanyl of
2 mcg/ kg, carry
fewer doses of
propofol for LMA
Classic insertion

Non reported

frequency of
movements.
Improved
cardiovascular
stability with
butorphanol
compared
with a
combination
of propofol
and fentanyl.

Both doses of
fentanyl (1
and 2 mcg/kg)
provide
comparable
insertion
conditions for
LMA.
Fentanyl in the
lower dose
provides a
more stable
hemodynamic
profile

RESULTS
Hemodynamic stability
Subhadra et al. 4 conducted a prospective, randomized single-center study in 2014, which
included sixty patients admitted for lower abdominal and lower limb surgery. Patients were divided into
the Fentanyl group, which received 1 µg/kg, and the dexmedetomidine group, received dexmedetomidine
1 µg/kg diluted in 10 ml normal saline (NS); both groups were induced with propofol 2mg/kg.4
Researchers examined patients for 90 seconds after propofol injection for jaw relaxation and proceed to
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laryngeal mask airway (LMA) insertion. Heart rate (HR), systolic blood pressure (SBP), diastolic blood
pressure (DPB), arterial oxygen saturation, and respiratory rate (RR) parameters were recorded before and
at the end of the 1st, 2nd, 3rd, 5th, and 10th minutes after insertion of LMA.4 The study found that more
patients in the Fentanyl group developed apnea compared to the dexmedetomidine group, values reported
were 40% vs. 67% respectively; P<0.01.4 Researchers found reductions in SBP, DBP, MAP were greater
in the fentanyl group; P < 0.001 than in the dexmedetomidine group; P < 0.05.4 The study reveals that
hemodynamic parameters were more stable in patients that received dexmedetomidine than in patients
that receive Fentanyl co-administered with propofol for LMA insertion.4
From the Surabhi et al. 11 study published in 2014, dexmedetomidine - propofol was compared to
fentanyl - propofol during laryngeal mask airway insertion in elective surgery. Patients received 1μg/kg
of dexmedetomidine and fentanyl, respectively, followed by propofol 2.5 mg/kg. This prospective,
randomized, double-blind comparative study included 60 patients aged 20 and 50 years with an American
Society of Anesthesiologists (ASA) I-II category, MPC grade I and II, scheduled for short elective
surgeries.11 Surabhi et al. recorded extensive data regarding hemodynamic responses including HR, BP,
RR at baseline, just after administering the study drug, immediately before LMA insertion, 30 s, 1min,
2mins, 3mins, 5mins, 7mins, 10min after LMA insertion.11 Bradycardia was defined as heart rate < 15%
of the baseline or < 50/mins.11 A P value was established as < 0.05 for statistical significance.11 The
analysis of the results revealed a statistically significant fall; P < 0.05 in the mean SBP seen during the
post-LMA, at 1 min, 2 mins, and 3mins compared to the Pre LMA mean SBP in the dexmedetomidine
group.11 The fentanyl group showed statistically significant values in the mean SBP during the post-LMA
phase compared to the pre-LMA mean SBP; P value= 0.003. 11 The study revealed that Dexmedetomidine
gives better insertion conditions and better attenuation of pressor response to LMA insertion than
fentanyl.11
Rustagi et al. 14 conducted a randomized controlled double-blinded study on insertion conditions
with propofol induction after pretreatment with dexmedetomidine or fentanyl. The randomized controlled
double-blinded study was conducted with eighty ASAI/II patients undergoing general anesthesia.14
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Groups were randomized into group D= 40 and group F=40; group D received 1μg/kg dexmedetomidine
over 10 minutes followed by 5ml of 0.9% NS over 2 minutes; group F received 10 ml of 0.9%NS over 10
minutes followed by fentanyl 1 μg/kg over 2 minutes.14 Propofol 2 mg/kg was given thirty seconds after
study groups. Gupta et al. 14 used the Modified Scheme of Lund and Stovener to assess the overall
insertion condition of LMA. Excellent- no gagging or coughing, no laryngospasm, no patient movement;
Good- Mild to moderate gagging or coughing, no laryngospasm, mild to moderate patient movement,
Poor- Moderate to severe gagging or coughing, no laryngospasm, moderate to severe patient movement,
Unacceptable- Severe gagging or coughing, laryngospasm, severe patient movement. The overall
insertion condition, according to Lund and Stovener, were comparable in both groups, but
dexmedetomidine provided better jaw relaxation as assessed by Young's criteria, with 97.5% of patients
having absolute jaw relaxation compared to 87.5% with fentanyl.14 In the fentanyl group, 12.5% of
patients had moderately relaxed jaw and required additional boluses of propofol to facilitate LMA
insertion.14 The study did not find this observation statistically significant. 14 Still, vastly clinically
significant finding as added increments of propofol in group F led to hypotension episodes in <15%
baseline MAP. 14 The research also concluded that apnea was significantly higher in group F 18/40 than
group D 3/40; P < 0.0001. A total of 10.3% drop in MAP from baseline was seen in group F compared to
5.6% in group D; P = 0.002.14
A randomized controlled trial from Dwivedi et al. in 2016 evaluated the hemodynamic responses
for LMA insertion using propofol and butorphanol compared to propofol and fentanyl for induction.18 The
study had two groups: Group F, propofol, fentanyl, Group B, propofol, and butorphanol.18 A total of
hundred patients of ASA I and ASA II with Mallampati-II and III between 18–60 years were randomly
selected and divided into two groups with 50 on each.18 All hemodynamic parameters were recorded,
including SBP, DBP, MAP, RR, and HR.18 A significant decrease in the mean arterial pressure was
noticed in the propofol group over the first 5 min of induction.18 The values of mean SBP, DBP, and
MBP in this study were lowest at 5 min of insertion of LMA with a statistically significant decrease in
Group F than in Group B.18 After premedication, a transient increase in the mean HR, 92.38 ± 16.00, Z =
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1.32; P = 0.188, and a significant rise in the mean SBP, 125.86 ± 13.96, Z = 2.77; P = 0.007, was
observed in Group B.18 Also, the MBP, 92.75 ± 1.07 was significantly higher, Z‐value = 2.15; P = 0.033,
after premedication in Group B.18 After insertion of LMA at 1 min, 3 mins, and 5 mins, a statistically
significant drop in mean heart rate, SBP, DBP, and MBP were noted in Group F as compared to Group B,
P < 0.05.18 After extubation, all the vital parameters started returning to premedication values; however,
the increase in the mean SBP and MBP after extubation was statistically significant in Group B; Z = 2.99;
P = 0.003 and Z = 2.91; P = 0.004, respectively as compared to Group F.18 This study demonstrated a coinduction agent with propofol 2.5 mg/kg, such as butorphanol 30μg/kg as found to be a better alternative
to fentanyl 1.5 mg/kg as far as hemodynamic stability.18 The effect of butorphanol leading to stable
hemodynamics by stabilizing bradycardia was felt to be related to the release of the catecholamines from
this co-induction agent.18
Preservation of spontaneous respirations
In 2015 Ramaswamy et al. conducted a ten-month prospective, double-blind, randomized study
on eighty patients of ASA physical status 1 and 2 randomly divided into two groups of 40 patients each. 1
Both groups were comparable in terms of the distribution of age, sex, and weight.1 Researcher used
Statistical Package Software Statistical Analysis to calculate the sample size with an alpha error of 0.05,
confidence of 95%, infinite population.1 Group D received dexmedetomidine 1mcg/kg, and group F
received fentanyl 1 mcg/kg IV over 2 minutes; both groups were induced with propofol 2mg/kg, and 90
seconds later, LMA was inserted.1 During the study, the parameters recorded were apnea time- the time
from last spontaneous breath after propofol administration to first spontaneous breath, HR, RR, SBP,
DBP, and oxygen saturation.1 The Muzi scoring system was used to evaluate patients' responses to LMA
insertion.1 The scoring system includes jaw mobility graded as 1-fully relaxed, 2-mild resistance, 3-tight
but, opens, 4-close; coughing/movement graded as 1-none, 2-one or two coughs, 3-three or more coughs,
4- bucking/movement.1 Score ≤2 was considered optimum for LMA insertion.1 The study found that 37
patients, 92.5% patients of group D and 35, and 87.5 % of group F had scores of <2, thus demonstrating
the acceptable condition for insertion of LMA. The incidence of adverse events was found to be
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statistically insignificant. The incidence of apnea was recorded to be longer in group F than in group D,
290s, and 227s, respectively.1 The study concluded that incidences of adverse events were comparable
and statistically insignificant in both groups, but dexmedetomidine showed to be superior in preserving
patients' respiration.1
Choudhary et al. performed a prospective, randomized, double-blinded, parallel-group clinical
trial.6 The study included seventy-four ASA I and II patients who were randomly chosen to receive either
dexmedetomidine 1μg/kg or fentanyl 1μg/kg.6 Propofol 2.5 mg/kg was administered for induction after
thirty seconds of administering the study drugs.6 Researchers used the Muzi score system to calculate the
sample size.6 A difference in 23.4% in jaw relaxation grade 1 was found between dexmedetomidine and
fentanyl groups; using power analysis, 37 patients in each group were calculated considering α error of
5% and power of 80%.6 In group dexmedetomidine, three patients had Muzi score >2; two patients
moved, and one had mild resistance to jaw mobility; none of the patients had coughing or bucking during
LMA insertion.6 On the fentanyl group, six patients scored > 2; three patients had coughing, four patients
moved during LMA insertion.6 Choudhary et al.6 concluded that baseline HR, SBP, and MAP were
comparable in both groups, but the incidence of apnea was significantly higher in the fentanyl group; P
0.011; dexmedetomidine also provided better postoperative analgesia.
Gupta et al.7 compared the hemodynamic and respiratory parameters, apnea time, and patient's
response to LMA insertion using dexmedetomidine-propofol and fentanyl-propofol combination.
Propofol is notable for providing superior airway reflexes suppression, but propofol causes
cardiorespiratory depression and does not offer analgesic effects when used without premedication.7 The
double-blind, randomized clinical study was carried out in 140 healthy patients with ASA grades I and II.7
The fentanyl group received 1μg/kg, and Propofol 2mg/kg IV, and the dexmedetomidine group received
1μg/kg and propofol 2mg/kg. Parameters such as HR, RR, SBP, DBP, MAP, and oxygen saturation were
recorded before induction, 30 seconds after induction, 1, 3, 5, 10, 15, 30, 45, and 60 minutes after
insertion of LMA.7 Apnea time was noted. Jaw mobility, coughing, and gaging were also noted and
scored according to the scoring system modified by Muzi.7 Patients that received fentanyl had a higher
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rise in HR compared to patients that receive dexmedetomidine.7 A single dose of dexmedetomidine
reduces norepinephrine release by stimulation of presynaptic alpha 2 adrenoreceptors as much as 92% in
young, healthy volunteers, which decreases HR.7 Gupta et al. found that 58 patients that received
dexmedetomidine had spontaneous respirations and 12 showed breath-holding while in the group that
received fentanyl 36 patients had spontaneous respirations and 34 showed breath-holding.7 The study
found this difference to be statistically significant; P < 0.05.7 The study concluded that dexmedetomidine
is superior to fentanyl in maintaining stable hemodynamics, preserving respirations, and providing better
LMA insertion conditions.7
The prospective randomized study by Uzümcügil F et al. from 2008 included a total of 52
patients, aged 26–65 years old with an ASA physical status I–II, scheduled to have minor urological
procedures.10 The patients meeting inclusion criteria were randomized into two groups.10 A group F
included those induced with propofol and fentanyl, whereas group D was treated with propofol and
dexmedetomidine.10 The Data analysis was performed using SPSS for the categorical variables to include
Student's t-test and ANOVA. A P < 0.05 was considered statistically significant.10 Two groups were
similar in terms of gender distribution, age, weight, and duration of surgical procedures, and baseline SBP
and mean BP (MBP) were similar.10 The emergence time was greater in Group D.10 The emergence time
was 81–385s, mean: 253.5 s in Group F and 85–992s, mean: 397.5s, in Group D; P =0.001.10 The variable
apnea was greater in Group F, 24 patients, than in Group D, 11 patients; P =0.01.10 Group D, the
respiratory rates increased compared to the baseline.10 Subsequently, it was concluded that
dexmedetomidine, when used before propofol induction, provides successful laryngeal mask insertion
comparable to fentanyl while preserving respiratory functions more than fentanyl.10
Tan et al. in 2010 reported the optimum Fentanyl dose in combination with propofol for classic
LMA insertion.13 The study was a randomized, controlled trial with a sample size of Seventy-five ASA I
or II patients randomly assigned to five groups of fentanyl dosage: 0 μg.kg-1 placebo, 0.5 μg.kg-1, 1.0
μg.kg-1, 1.5 μg.kg-1 and 2.0 μg.kg-1.13 Data was recorded to include hemodynamic parameters and
apneic events.13 Prolonged apnea was defined as more than 5 mins.13 A grading system was utilized to
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determine the optimal score for insertion and calculated by adding the grades for all the insertion
condition categories of 1, 2, or 3.13. A total score of 6 was considered optimal.13 The data analysis was
carried through the chi-square test for trends' linear association,' and it was used to compare insertion
conditions with respect to increasing dosage.13 A 5% level of probability, P <0.05, was utilized as a
criterion for significance.13 This study found a high rate of the successful first attempt at insertion with
1μg.kg and 1.5μg/kg, 93% and 87% respectively, compared to 87% in the 2.0 μg.kg-1 group.13 The 1.0
μg.kg-1 group also achieved an 80% optimal insertion conditions score of 4, compared to 73% in the 1.5
μg.kg-1 group and 80% in the 2 μg.kg- group.13 The study found a significantly high incidence of
prolonged apnea occurred mainly in the 2μg/kg-1 group by 60%.13 The study concluded that even at low
doses of fentanyl of 1.0 μg.kg , patients experience prolonged episodes of apnea.
Joshi et al. study in 2014 evaluated the effects of fentanyl administration before induction and
LMA placement.17 This randomized double-blinded controlled trial included 100 patients with an ASA
physical status 1, 2, and 3 patients undergoing ambulatory surgery.17 Patients were administered fentanyl
1μg/kg, n=51 or saline, n=49, 3 to 5 minutes before induction with propofol 2-2.5 mg/kg IV, followed by
LMA placement.17 The data were analyzed with Chi-square or Fisher's Exact tests to assess differences in
breath-holding and postoperative categorical outcomes between the two study groups.17 Cochran-MantelHaenszel test was performed to investigate the anesthetic technique's effect on apnea after adjusting for
smoking status.17 The fentanyl pretreatment group revealed a higher frequency of apnea, 94% vs. 64%;
P=0.0003, requiring a longer duration of manual ventilation (3 [interquartile range (IQR), 1.5-5] min vs. 1
[0-1.5] min; P=0.0001, at induction.17 The rates of intraoperative breath-holding, 6.1% vs. 8.5%, in the
two groups were similar.17 This study concluded that pre-induction with fentanyl increased the frequency
of apnea at induction and manual ventilation duration.17
Propofol dosage reduction during induction.
Shalaka et al in 2016, conducted a prospective randomized, double-blind study.8 The study
included a total of 60 ASA I and II patients of either sex scheduled for short surgical procedures under
general anesthesia.8 Patients with neck and facial burns, reduced mouth opening, BMI>30, on B-blocker
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therapy, basal heart rate <60, and known egg allergy was excluded.8 The researchers had two different
groups, including a group D with dexmedetomidine and propofol and a second group F with fentanyl and
propofol.8 The data was analyzed, demonstrating that the induction dose and increments of propofol
required in group D were significantly lower, P <0.001.8 Other measured parameters, such as jaw
relaxation as assessed by Young's criteria, were comparable; P= 0.41, between the two groups.8 The
hemodynamics, including heart rate variation and mean arterial pressure results, were not statistically
significant between the two groups.8 Apnea of more than 30 seconds after induction occurred in both
groups and was comparable.8 The study concluded that Dexmedetomidine significantly reduces the
requirements of induction dose propofol for PLMA insertion.8
A blind randomized controlled trial was conducted by Yoo J et al. l in 2017.15 A total of 40
patients, aged 19–60 years with ASA physical status I–II, and scheduled to undergo elective minor
surgery in which the use of LMA was indicated were included.15 There were two groups, the
dexmedetomidine group evaluating the effect of dexmedetomidine,1μg/kg, pretreatment on the median
effective dose (ED50) of propofol vs. the control group with propofol alone to evaluate successful LMA
insertion.15 The ED50 of propofol for successful LMA insertion was determined by the modified Dixon's
up-and-down method.15 The ED50 of propofol was determined to be 1.9 mg/kg for LMA insertion with a
loading dose of 1μg/ kg dexmedetomidine over 10 min.15 ANOVA analyzed and recorded the
hemodynamic and BIS changes recorded. Statistical significance was accepted when the P-value was
<0.05.15 The ED50 of propofol for smooth insertion of the LMA, as determined by the Dixon's up-anddown method, was significantly higher in the control group than in the dexmedetomidine group, 3.1 ± 0.4
vs. 1.9 ± 0.3 mg/ kg, P < 0.001.15 Using isotonic regression and a bootstrap approach, the ED50 of
propofol was 2.9 mg/kg, 83 % CI 2.5–3.3 mg/kg, and 1.8 mg/kg, 83 % CI 1.8–2.1 mg/kg, in the control
and dexmedetomidine groups, respectively.15 The MAP was higher, and HR was lower in the
dexmedetomidine group than in the control group during drug infusion and LMA insertion.15 The BIS
value was lower in the dexmedetomidine group during drug infusion.15 The apnea time was 43 ± 50 s in
control and 54 ± 48 s in the dexmedetomidine group, but there was no statistically significant
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difference.15 The study advised pretreatment with dexmedetomidine 1 μg/kg could reduce the propofol
requirement by 38 % for facilitating LMA insertion without prolonged respiratory depression and
hemodynamic instability.15 One limitation of this study found the estimated propofol dose for facilitating
LMA insertion was limited to the fixed-dose of dexmedetomidine.15

Reduction in Minimum Alveolar Concentration
Yao et al 16 conducted a prospective, randomized, double-blind, placebo-controlled study on
intranasal dexmedetomidine premedication and its effect in reducing the minimum alveolar concentration
of sevoflurane for laryngeal mask airway insertion in children.16 The study included ninety ASA physical
status I patients aged 3–7 years. Patients were randomized to three equal groups to receive saline (Group
S), dexmedetomidine 1mcg/ kg (Group D1), or dexmedetomidine 2 mcg/kg (Group D2) approximately 45
min before anesthesia.16 Researchers used Dixon's up-and-down method to assess alveolar concentration
for laryngeal mask airway insertion. Yao et al. concluded that intranasal dexmedetomidine premedication
of 1 and 2 mcg/kg was associated with a reduction in sevoflurane from 1.92% to 1.53% and 1.23%,
corresponding to a decrease of 20% and 36%, respectively.16 Emergence delirium, defined as peak PAED
score ≥10, was significantly lower in Groups D1 and D2 than in Group S; P < 0.001.16 Parents
satisfaction scores were significantly higher in Groups D1 and D2 than in Group S; P < 0.001.16 The
induction quality, delirium scores, and the parent's satisfaction yield a P value < 0.05 and were considered
statistically significant.
DISCUSSION
Summary of Evidence
Eleven prospective, double-blind, randomized studies with a total of 836 patients and two
randomized single-center studies with a total of 100 patients were included in this Quality Improvement
Project. Several studies were excluded, including studies which had an inappropriate publication date i.e.,
older than 2010), wrong population (e.g., non-surgical patients on either treatment of propofol-fentanyl
combination or propofol- dexmedetomidine combination), and wrong intervention (e.g., patients receiving
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medications in the postoperative period for pain control). Of the thirteen articles found, eight were rated
as high quality, and seven were rated as medium quality based on Johns Hopkins' appraisal scale. Due to
larger sample sizes, well-defined methodology and inclusion criteria, as well as rigorous statistical
methods, eight of the articles met the criteria for high-quality level 1 evidence. Seven articles appraised
by the Johns Hopkins' tool, as medium-quality level 2 evidence had small sample sizes or mediocre
defined inclusion criteria and methodology.
Of the thirteen articles analyzed, all studies recommended using propofol- dexmedetomidine
combination on induction to achieve better laryngeal mask insertion condition while preserving
respiratory functions.11 According to Uzümcügil F et al., dexmedetomidine is beneficial for sedation and
analgesia without resulting in cardio-respiratory depression.10 All RTCs concluded that apnea time was
significantly shorter in patients who received dexmedetomidine compared to fentanyl. Most of the
subjects by Joshi et al. study who received fentanyl upon induction had apnea, requiring manual
ventilation for a more extended period.17 Subhadra et al. also reported a statistically significant drop-in
respiratory rate from baseline value in patients induced with propofol and fentanyl.4
Five RCTs of high-quality level 1 evidence showed a statistically significant drop-in mean heart
rate, SBP, DBP, and MBP in patients that received fentanyl compared to dexmedetomidine.4,11,14,17,18.
Surabhi et al. recorded a statistically significant rise in SBP in the post-LMA phase than in the fentanyl
group, which was not seen in the dexmedetomidine group; P value=0.003. 11 According to Subhadra et
al.4 patients induced with fentanyl had a statistically significant decrease in MAP, SBP, and DBP from
baseline after induction with propofol. Although it has been reported that dexmedetomidine can cause a
dose-dependent reduction in arterial BP; Rustagi et al. found pre-administration of dexmedetomidine in
the dose of 1mcg/kg is reported to attenuate the decrease in blood pressure during propofol induction.14
Both fentanyl and dexmedetomidine are used in conjunction with propofol in order to reduce
propofol requirements for LMA insertion.14 According to Rustagi et al propofol at doses of 2.0-2.5mg/kg
decreases MAP due to its vasodilatory and myocardial depressing effects, which are shown to be
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potentiated by co-induction with fentanyl.14 Three double-blind RCTs showed that patients induced with
fentanyl required additional boluses of propofol due to inadequate jaw relaxation, coughing, and
movement.8,15,15 Induction doses of propofol range from 2 mg/kg to 2.5mg/kg, while fentanyl and
dexmedetomidine doses of 1mcg/kg were the only doses used in all thirteen studies. Choudhary et al.6
was the only study that used a higher dose of propofol, 2.5 mg /kg. Choudhary et al. also observed that
patients induced with propofol and dexmedetomidine had better postoperative pain scores when compared
to the fentanyl group due to dexmedetomidine action on α 2adrenoceptors in locus cerulean and dorsal
horn of the spinal cord.6
Limitations of the Quality Systematic Review:
An extensive data search was performed with criteria to include the comparison of
dexmedetomidine vs. fentanyl during induction for LMA insertion, and which resulted in limited
published available data. All studies, when comparing dexmedetomidine vs. fentanyl as an adjuvant
anesthetic during LMA insertion, represent a small population of patients evaluated for a combination of
two anesthetic drugs within the two different groups with Propofol being a primary anesthetic for both
groups.1,4,5-17 For this quality improvement project, the use of IV propofol alone during induction is
considered insufficient for adequate LMA insertion and, therefore, unethical to be used by itself.
1,7,10,14

Increased dose of propofol when used as a sole anesthetic tends to cause respiratory depression and

hemodynamic instability. 1,7,10,14
There was no evaluation of propofol as an individual sedative agent as a control group. The use
of propofol alone for sedation during LMA insertion is considered a high risk for respiratory
complications.6 Most of the research is randomized double-blinded, but no multicenter clinical trial was
available to address this subject better.1,4,5-17 As part of the evaluation, all reviewed studies are singlecenter without inclusion for other institutions with homogeneous inclusion criterias.1,4,5-17
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The bispectral index (BIS) is a very useful tool to assess levels of hypnosis and subsequently
levels of comfort, especially during LMA insertion or maintenance. From all the studies within this
Quality Improvement Project, only one considered the use of BIS during LMA insertion.15 Another study
in this review utilized the BIS as a monitoring tool to properly titrate desflurane during anesthesia
maintenance.17 Otherwise, there is a significant lack of utilization of the BIS monitor during induction for
LMA insertion, nor during anesthesia maintenance within currently available data when comparing
dexmedetomidine to fentanyl.
The hemodynamics at baseline might not necessarily be similar among these groups prior to
LMA insertion, and the result description or the statistical analysis were not adjusted given the small
population and demographic included in each randomized clinical trial between the dexmedetomidine and
fentanyl. Also, there is great variability in hemodynamics measurement and results among the revised
clinical trials during LMA insertion and post-induction during anesthesia maintenance.1,4,5-17 Although the
focus on most of these examined clinical trials remains on hemodynamics and respiratory status,
including episodes of apnea, there is no homogeneity to determine whether the significant changes
occurred during induction vs. post-induction. There is no significant data available during the
postoperative state when comparing these two anesthetics.
During the postoperative state, the use of pain, recovery, and sedation scales are very useful in
determining and guiding the management of patients as part of the post-surgical intervention. There is
very limited data regarding the use of pain scales such as the visual analog scale (VAS) on these studies
reviewed. Only one study demonstrated significantly lower VAS values within the group of patients that
received dexmedetomidine during the postoperative state.6 One study reported the utilization of lidocaine
during induction of anesthesia for LMA insertion. The addition of lidocaine as an adjuvant continues to
grow in practice as a standard of care, but none of the studies on this review reports postoperative pain
scales or their relationship to the use of dexmedetomidine vs. fentanyl.6
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Another limitation within the currently available data is the lack of generalizability of the clinical
data to include a wider demographic population. According to the CDC for 2017-2018, the percent of
adults aged 20 and over who are overweight, including obesity, is 73.6%. Weight criteria were
commonly used as exclusion criteria in this quality improvement project. Shalaka et al., Yoo et al. and
Rustagi et al. studies did not include patients with a BMI > 30 Kg/m2.8,14,15 Ramaswamy et al. and Gupta
et al. excluded patients with a weight more than 80kg whereas Sintavanuruk utilized a 40 - 85Kg range
and did not utilize the BMI as criteria.1,7,12 Choudhary et al. utilized the BMI > 35 Kg/m2, whereas Joshi
et al. used BMI > 40 Kg/m2 as exclusion criteria.6,17 The study from Uzümcügil did not include a weight
exclusion criteria reporting 75.7 Kg +/- 11.85 in the Fentanyl group and 76.3 Kg +/-9.93 in the
dexmedetomidine demonstrating how the average weight can easily be more than 80 Kg although a BMI
level could not be determined.10 Surabhi et al. did not address weight during their study.11 The above
results in a substantial limitation as there is a lack of data understanding the reaction and side effects of
dexmedetomidine vs. fentanyl on this population as it affects hemodynamics and respiratory parameters,
as an example.
Recommendations for Future Research
When evaluating the available data on comparisons for dexmedetomidine vs. fentanyl during
induction for LMA insertion, the current publications are limited with small populations. There is no
multicenter clinical trial from all available reports within this quality improvement project. Multicenter
clinical trials represent the best available data as it includes a larger population with demographic
variability and a better general population analysis as many institutions would participate. The practice
changes of using dexmedetomidine versus fentanyl upon induction have changed clinical practice away
from the use of opioid-based medications. Although currently available data suggest and favor the use of
dexmedetomidine over fentanyl during induction for LMA insertion, a multicenter clinical trial would
bring generalizability in the surgical population in supporting this practice change. A multicenter clinical
trial would impact the current AANA guidelines for induction during LMA insertion with high-quality
and reliable clinical data.
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Future research can expand inclusion criteria of the following: type of surgery, ASA
classification, mallampati classifications, 1,2 3 & 4, BMI, and desired depth of anesthesia. Multiple
measurable variables come into play within the complex induction process of anesthesia during LMA
insertion. For purposes of comparison between dexmedetomidine and fentanyl, the following variables
should be researched, graded insertion conditions, baseline hemodynamic levels during induction and
maintenance, episodes of apnea, and emergence time. Hemodynamics should include SBP, MAP, DBP,
and heart rate. The definition of an episode of apnea should be supported by a capnograph. One study
reported a longer apneic time when using fentanyl (290 sec) when compared to dexmedetomidine (227
sec).1 Another study also reported apneic events in the fentanyl group 237.78 ± 21.36 sec, statistically
different to dexmedetomidine, with 208.74 ± 15.69 sec.7 Another study defined apnea as more than 30
seconds and found it to be comparable in both groups of anesthetics used, whereas similar criteria on
Rustagi al.al and on Joshi al.al revealed significantly higher incidence and mean duration of apneic events
within the fentanyl group.8,14,17 Joshi et al. utilized minutes as the unit of measurements instead of
seconds.17 It might be appropriate to define an episode of apnea as more than 30 seconds, but it appears
that most apneic episodes could easily reach a mean of 200 seconds long or more based on this systematic
review. Although longer episodes of apnea are more concerning for clinical outcomes, different levels of
severity should be better defined. Mild apnea is defined between 30 to 200 sec, moderate between 200 to
300 sec, and severe as more than 300 sec, but this might be difficult to define given multiple factors such
as the surgical scenario, patient's age, medical history, ASA classification, or the patient's hemodynamics.
Another aspect to consider for future research is the utilization of pain monitoring tools for the
intraoperative and postoperatively assessment when comparing dexmedetomidine to fentanyl. There is
limited data on the use of the BIS during induction as only one study published a significantly lower score
on the BIS values when using dexmedetomidine, demonstrating its superiority to fentanyl.15 There is also
limited intraoperative data when monitoring for pain levels as there is only one study utilizing BIS
monitor to titrate desflurane during anesthesia maintenance properly, but it does not reflect any benefit of

Page 31 of 72

32
dexmedetomidine over fentanyl.17 The postoperative state tools to monitor pain include the use of a visual
analog scale (VAS), but data was found to be limited when comparing dexmedetomidine to
fentanyl. Choudhary et al. suggest there are superior results when using dexmedetomidine during LMA
insertion, as the VAS showed lower values in the postoperative state.6 Future research in this area would
benefit from the inclusion of pain measuring tools such as BIS or VAS during anesthesia induction,
maintenance, or even in the postoperative state when studying dexmedetomidine vs. fentanyl as adjuvant
anesthetics. Also, it is unknown how the use of lidocaine within this group of anesthetics would influence
pain levels on the patient during the intraoperative state and the postoperative state.6
Recommendations for Practice Presented in an Algorithm
Dexmedetomidine dose of 1mcg/kg, 30 seconds prior to induction of propofol at 1.5mg/kg,
provides successful LMA insertion. Successful insertion is defined by having a fully relaxed jaw, absence
of cough, minimum effect on the adrenergic state of the patient, and preservation of respiratory drive.
Among the studies, the combination was found to preserve respirations.10 The double-blind RCT
conducted by Yoo J et al.15 determined that using dexmedetomidine 1mcg/kg can potentially reduce the
propofol requirements by 38%. The RCT conducted by Rustagi et al. concluded that using
dexmedetomidine even at a lower dose of 0.5mcg/kg can be more effective than using fentanyl at
1mcg/kg in maintaining hemodynamic stability during extubation.14
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Adult surgical
patients undergoing
LMA insertion.

Dexmedetomidine
dose of 1mcgh/kg

Hemodynamic
stability

Followed by
propofol 1.5mg/kg;
30 seconds after

Propofol dosage
reduction during
induction

Preservation of
spontaneous
respirations

Figure 2. Algorithm for Perioperative Patients Undergoing LMA Insertion
CONCLUSION
Providing the best level of anesthesia during induction with LMA insertion remains an important
query in anesthesia. Propofol as the sole anesthetic does not appear to be appropriate and might even be
unethical for the patient's best depth of anesthesia during LMA insertion. 1,7,10,14 The need for anesthetic
adjuvants such as dexmedetomidine or fentanyl is frequently needed. The use of dexmedetomidine
compared to fentanyl appears to provide better insertion conditions and better attenuation of the
hemodynamic and respiratory stress response caused by the insertion of LMA. All thirteen RCTs suggest
the use of dexmedetomidine to be superior to fentanyl in preserving respirations and not needing
incremental doses of propofol. A multicenter randomized clinical trial with a larger demographic is
needed to provide generalizability and higher quality clinical evidence when comparing the use of
dexmedetomidine to fentanyl. Utilization of current available tools such as the use of BIS monitoring,
VAS, and other pain assessment tools would provide valuable clinical data on pain management
outcomes intraoperatively and postoperatively with a general anesthetic utilizing an LMA.
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IMPLEMENTATION
Setting and Participants
The setting will take place through an online survey and a Zoom PowerPoint educational module
consisting of a pre and post-test with the members of the Anesthesia Department from Envision Physician
Services at Memorial Regional Hospital. The preliminary study will include anesthesia providers such as
Certified Registered Nurse Anesthetists (CRNAs) and Anesthesiologists. The participation will be based
on individuals who were forwarded within the email list provided by Memorial Regional Hospital and
will be asked to provide feedback regarding the educational module's anesthesia providers' experience and
knowledge. The anticipated sample size will be between 15-20 participants.
Recruitment
The target population consisted of CRNAs and Anesthesiologists who have taken care of patients
during LMA insertion. Participants were identified through an email list provided by Memorial Regional
Hospital. The anesthesia providers within the email list were emailed an invitation and link to participate
in the educational module.
Description of Approach and Project Procedures
The primary methodology of the proposed project is to have the survey taker participate in an
online PowerPoint educational module that focuses on the difference between dexmedetomidine versus
fentanyl as adjuncts to propofol during LMA insertion. The project will be implemented by conducting an
online preassessment test that will assess the anesthesia provider's knowledge about the efficacy of
Dexmedetomidine- Propofol, and Fentanyl - Propofol for LMA insertion. The existing knowledge and
understanding of the anesthesia provider will be defined using a pre-evaluation tool that will influence the
intervention's information and determine the content or subject matter of the intervention.
The second phase will include an online PowerPoint presentation. The primary means of
learning will be through a voiceover PowerPoint presentation with information regarding the advantage of
using dexmedetomidine- propofol combination during LMA insertion. Anesthesia providers' education is
essential in bridging existing gaps in knowledge and supporting the need for additional tools to ensure
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optimal patient conditions during LMA insertion. Anesthesia providers will have the opportunity to
expand their knowledge about the benefits of using dexmedetomidine during LMA insertion. The delivery
of the presentation will offer insight for providers regarding the differences of using dexmedetomidinepropofol versus fentanyl-propofol combination. The empirical evidence supports an evidence-based
project with comprehensive information regarding the benefits of using a dexmedetomidine-propofol
combination to provide better insertion conditions and lesser hemodynamic response.
The third phase of the project will involve an online post-assessment test to identify
the anesthesia providers learned knowledge and perception of the intervention and the contents that were
delivered. This information will provide greater feedback regarding the impact of the educational
intervention and will determine how to best move forward in expanding the use of dexmedetomidine
during LMA insertion. The pre/post-testing will provide relevant information regarding the benefits of
using dexmedetomidine as an adjuvant to decrease the requirement of propofol and maintain stable
hemodynamics intraoperatively. At the end of the educational tool, feedback will also demonstrate if the
information provided will improve anesthesia providers' knowledge.
Protection of Human Subjects
Anesthesia providers participating in the survey remained anonymous, and the data was secured
by using unique code identifiers. The digital data collected from the pre-test and post-test were protected
by a laptop password and spyware. Using laptop passwords and spyware ensured the safety of the data.
There are no perceived risks to the study as it only requires the time spent by each anesthesia provider in
the educational module, which took less than 20 minutes to complete.
Data collection and analysis
For the Quality Improvement Project, the primary instruments included preassessment and postassessment testing applications to determine the effects of the educational module. Both tests will be
conducted using surveys utilizing Qualtrics that will determine if participants understand the difference
between the adjuvants, dexmedetomidine, and fentanyl, during LMA insertion. The survey consisted of
15 questions that focus on knowledge and practice. The pre-test survey will gauge baseline knowledge. In
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contrast, the post-test survey will determine the participant's knowledge from the educational module and
the application of knowledge gained to professional practice. The data collected will be confidential, and
no subject identifiers will be recorded during any component of the study.
Data Management and Measure
The investigator for the project will be the DNP student responsible for obtaining the members of
the Anesthesia Department at Memorial. Regional Hospital via email list for the administration of the preand post-survey and a PowerPoint educational module. Each question will be measured, and the responses
recorded to identify the knowledge base before and after the educational module. No personal identifiers
will be recorded for each of the study participants so that confidentiality will be protected. The impact of
the educational module will be based upon the results of the pre-and post-test survey instruments.
Through the statistical analysis, the study results will likely identify patterns that will be used to
determine the effectiveness of the educational module and if the module will improve anesthesia
providers' knowledge. The co-investigator will store the data collected in a password-protected laptop
computer.
IMPLEMENTATION RESULTS
Pre/Post-Test Demographics
The pre-test demographics are shown in Table 3., shown below.
Pre-Test Participants Demographics
Demographic
Total Participants
Gender
Male
Female
Age
25-35
36-45
46-55
56-66
Ethnicity
Hispanic
Caucasian
African American

n (%)
10 (100%)
3 (30%)
7 (70%)
7 (70%)
2 (20%)
1 (10%)
0 (40%)
2 (20%)
5 (50%)
1 (10%)
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Asian
Other
Position/Title
CRNA
MD/DO
Years of Experience
1 to 2 years
2 to 5 years
5 to 10 years
More than 10 years

0 (0%)
2 (20%)
10 (100%)
(0%)
6 (60%)
3(30%)
1(10%)
0 (0%)

There were 10 participants in the pre-test demographics. Most of the participants were female
(n=7, 70%) instead of male (n=3, 30%). There was also a range of ethnicities represented: Caucasian
(n=5, 50%), Hispanic (n=2, 20%), African American. (n=1, 10%), and other (n=2, 20%). Information was
obtained regarding the participant's role at the hospital. It was found that all participants were CRNAs.
The participants were questioned about the length of time practicing, finding that the practice period
ranged: 1-2 years (n=6, 60%), and 2 to 5 years (n=3, 30%). The participants consisted of DNP-prepared
CRNAs (n=7, 70%) and Master level prepared CRNAS (n=3, 30%).
Pre-Test Likelihood of Utilization of Dexmedetomidine in Patients Undergoing Laryngeal Mask
Insertion
The pre-test contained information regarding the benefits of using dexmedetomidine versus
fentanyl as an anesthetic adjunct during LMA insertion. Most participants (n=8, 80%) stated that they
were somewhat likely to utilize dexmedetomidine on induction to achieve better laryngeal mask insertion
conditions while preserving respiratory function. The survey concluded that most respondents (n=8, 80%)
were unaware of how much dexmedetomidine pretreatment could reduce propofol requirements during
LMA insertion. This group of participants admitted to not knowing that the use of dexmedetomidine
could reduce propofol requirements by 38%.
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Pre-Test Identification of Current Knowledge about Perioperative Management of Surgical
Patients Receiving Dexmedetomidine as an Anesthetic Adjunct to Propofol to Facilitate Laryngeal
Mask Insertion.
The survey focuses on identifying the benefits of utilization of dexmedetomidine as an anesthetic
adjunct during LMA insertion. Most of the participants understood the mechanism of action of
dexmedetomidine; the question was correctly answered by 9 participants (n=9, 90%). When asked about
the benefits of dexmedetomidine use, all 10 participants answered the questions correctly (n=10, 100%).
All participants (n=10, 100%) answered correctly when questioned about dexmedetomidine’s side effect
profile. The participants knew the side effects of fentanyl, when asked about the most common side effect
of fentanyl (n=8, 80%), answered correctly. The participant's scores improved in the post-test when asked
questions pertaining to the dose of dexmedetomidine recommended to blunt the sympatho-adrenal
responses to laryngeal mask insertion (n=10, 100%). The participants were asked questions about the
recommended dose of propofol and dexmedetomidine combination that provided the best insertion
conditions without compromising the patient’s hemodynamic state. Participant's scores showed a
universal improvement upon the comparison of the pre-and post-survey. Table 4 shows the difference in
responses from the pre- to post-test.
Table 4. Difference in Pre- and Post-Test Knowledge
Questions
Select which statement is TRUE about dexmedetomidine

Pretest
90%

Posttest
100%

Difference
10%

In which receptor does dexmedetomidine exert its action

100%

100%

0%

What are the MOST common side effects of fentanyl?

100%

100%

0%

What is the MOST common side effect of dexmedetomidine?

100%

100%

0%

Which dose of dexmedetomidine has been reported to blunt the
sympatho-adrenal responses to laryngeal mask insertion?

40%

100%

60%

How much could dexmedetomidine pretreatment reduce propofol
requirements during LMA insertion?

60%

100%

40%

Page 38 of 72

39
According to research which of the following combination of
induction agents provides the best insertion conditions without
compromising the patient's hemodynamic state?

80%

100%

20%

Which statement is CORRECT about fentanyl?

80%

100%

20%

Which of the following statement is CORRECT about
dexmedetomidine?

80%

100%

20%

How much rise in systolic blood pressure can be seen in a patient
treated with fentanyl during the Post LMA phase?
How likely are you to use dexmedetomidine as an alternative to
fentanyl during LMA insertion?

0%

100%

100%

80%

100%

20%

How likely are you to recommend the use of dexmedetomidine over
fentanyl during LMA insertion?

80%

100%

20%

On average, the scores on the post-test increased compared to that of the pre-test after the
participants viewed the online PowerPoint presentation. All the participants improved knowledge about
the benefits of utilizing dexmedetomidine versus fentanyl as an adjunct to propofol during LMA
insertion. Most of the participants report improved knowledge about how much dexmedetomidine
pretreatment could reduce propofol requirements during LMA insertion (n=8, 80%). Questions regarding
dexmedetomidine on the mechanism of action, benefits of use, and side effects, there was no decipherable
proof of learning as all the participants answered the questions correctly on the pre-and post-test (n=10,
100%). Most of the participants report improved knowledge about the correct dosage of dexmedetomidine
reported to blunt the sympatho-adrenal responses to laryngeal mask insertion (n=6, 60%). Lastly, all the
participants in the post-test stated they would be likely to use and/or recommend dexmedetomidine over
fentanyl as an anesthetic adjunct during LMA insertion (n=10, 100%).
Post-Test Likelihood of Utilization of Dexmedetomidine in Patients During LMA Insertion
Most of the participants stated they were somewhat likely to utilize dexmedetomidine in patients
undergoing LMA insertion in the pretest (n=8, 80%). The post-test showed that all eight participants
changed their answer from “somewhat likely” to “extremely likely” (n=8, 80%). The post-test not only
showed an increase in knowledge but showed that all the participants were “extremely likely” to
recommend the use of dexmedetomidine versus fentanyl during LMA insertion.
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Summary
Overall, the results reflected an improvement in knowledge based on the pre-test and post-test
scores. Knowledge showed an average gain of (25%). In addition, the post-test demonstrated that
participants are extremely likely (n=4, 80%) or somewhat likely (n=2, 20%) to use a dexmedetomidinepropofol combination for LMA insertion.

Summary
100

80
60
40
20
0

Knowledge

Will Use/Recommend Utilization of
Dexmedetomidine as an Anesthetic Adjunct
During LMA insertion
Pre-test

Post-test

IMPLEMENTATION DISCUSSION
Limitations
Limitations of the study include a small sample size; the survey was emailed to the
members of the Anesthesia Department at Memorial Regional Hospital. There were 56 emails on the list;
however, only ten people completed the survey. A larger sample size is preferred to enhance the study's
findings and offer a sample size that mirrors Memorial Regional Hospital's anesthesia practitioners. The
survey link, which included a pre-test, a narrated PowerPoint presentation, and a post-test, was available
online for two weeks; it is possible that lengthening the time of survey availability may have produced
more responses. Lastly, the study was executed completely online, preventing it from being distributed
through other modalities.
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Future Implications for Anesthesia Practice
The literature demonstrated that hemodynamic parameters were more stable in patients that
received dexmedetomidine-propofol combination than in patients that receive fentanyl co-administered
with propofol for LMA insertion.4 Dexmedetomidine gives better insertion conditions and better
attenuation of pressor response to LMA insertion than fentanyl.11Even though the primary aim was to
demonstrate that dexmedetomidine possesses sedative, anesthetic-sparing, analgesic, sympatholytic, and
hemodynamic-stabilizing properties and lacks respiratory depression, it was discovered that
dexmedetomidine is also capable to significantly reduce the requirements of induction dose propofol for
LMA insertion.8,14,15 Incorporation of Dexmedetomidine has also reduced the need for NSAIDs, improved
quality of sleep, and exhibited a shorter recovery time in PACU.
When compared to dexmedetomidine, fentanyl has not only been found to suppress respiratory
drive but also is associated with nausea and vomiting.10 The use of fentanyl could imply the need for
additional medication to control the side effects of nausea and vomiting. Overall, dexmedetomidine is
found to be unique among other sedatives given its clinical safety regarding respirations even at high
doses. The Quality Improvement Project showed that the intervention of bringing awareness to these
factors was effective in increasing healthcare provider's knowledge and increased the likelihood of
utilizing/recommending dexmedetomidine as an anesthetic adjunct in patients undergoing LMA insertion.
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Appendix A
Evaluation Table 1
Citation

Subhadra P, Jayaram A, Rao M. Comparison of dexmedetomidine combined with
propofol Vs fentanyl combined with propofol for laryngeal mask
insertion. Journal of Clinical and Scientific Research. 2014;3(4):228.
doi:10.15380/2277-5706.jcsr.13.032.

Design/Method

Prospective, randomized single-center study which included sixty patients
admitted for lower abdominal and lower limb surgeries.
Sixty patients with lower abdominal and lower limb surgery were randomized
into Group F (n=30) and Group D (n=30). Thirty seconds after the study drug
(fentanyl 1 µg/kg in Group F and dexmedetomidine 1 µg/kg in Group D diluted in
10 mL normal saline over 2 min) was administered, induction was done with IV
propofol 2 mg/ kg in both groups. Ninety seconds after propofol injection, jaw
relaxation was assessed and LMA of appropriate size was inserted. If the first
attempt failed, another attempt with additional dose of IV propofol (0.5 mg/kg).

Sample/Setting

Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis

Findings

Results

Conclusions

Independent variable: IV1 is fentanyl and propofol vs IV2 dexmedetomidine and
propofol
Dependent variable: DV1 is systolic blood pressure (SBP); DV2 is diastolic blood
pressure (DBP); DV3 is mean arterial pressure (MAP); DV4 is respiratory rate
(RR); DV5 is SpO2; and DV6 is insertion condition.
Continuous variables: age, weight, heart rate, systolic blood pressure, diastolic
blood pressure, mean blood pressure and apnea time.
Apnea event: measured by SpO2 and respiratory rate
Insertion condition: jaw mobility (fully relaxed, mild resistance, tight but opens,
closed); coughing (none, 1 or 2 bouts of cough, 3 or more bouts of cough,
bucking); movements (mild, moderate, severe, none); and number of insertion
attempts.
Continuous variables were compared with student’s t-test. Parameters measured
over multiple points of time were analyzed using repeated measures ANOVA
with Bonfernii post-hoc test. Categorical variables were compared by Chi-square
test. Statistical analysis was done by using SPSS. A p-value of < 0.05 was
considered as statistically significant.
Both the groups were comparable in age weight, sex, age wise distribution and
insertion conditions. The apnea times were significantly shorter in group D than
in group F.
Baseline hemodynamics were comparable in both groups. Hemodynamics
parameters were more stable in Group D. There were less apneic events in Group
D as well.
The reductions in SBP, DBP, MAP was greater in Group F (p < 0.001). More
patients developed apnea in Group F than in Group D (p < 0.05). The incidence of
apnea was lower in group D compared to group F (40% vs 67%, p<0.01).
Dexmedetomidine combined with propofol provides the same conditions for
LMA insertion as fentanyl- propofol combinations with advantage of better
maintainance of haemodynamic parameters.
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Appraisal: Worth
to Practice/Level

THEME

Strength: dexmedetomidine appears to be a potential alternative to fentanyl.
Limitations: Small study. No control group with propofol was used alone. Patients
required different levels of analgesia and variable duration of anaesthesia, only
insertion conditions using propofol and dexmedetomidine were studied. BIS was
not used.
Risk of harm: risk of severe bradycardia in predisposed patients.
Feasibility of use: Adequate, less use of Fentanyl decreasing risk for side effects
such as apneic episodes. Dexmedetomidine is commercially available
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.

Evaluation Table 2
Citation

Ramaswamy AH, Shaikh SI. Comparison of dexmedetomidine-propofol versus
fentanyl-propofol for insertion of laryngeal mask airway. Journal of
Anesthesiology Clinical Pharmacology. 2015;31(2):217-220. doi:10.4103/09709185.155152

Design/Method
Sample/Setting

Prospective double blind randomized study
Eighty patients of ASA class 1&2 were randomly divided into two groups of 40
each. Group D received dexmedetomidine 1 mcg/kg and group F received
fentanyl 1 mcg/kg intravenously (IV) over 2 minutes. For induction, propofol
2mg/kg was given IV and 90 seconds later LMA was inserted.
Independent variable: IV1 is dexmedetomidine and propofol vs IV2 is fentanyl
and propofol
Dependent variable: DV1 is apnea time; DV2 is respiratory rate (RR), DV3 is
laryngeal mask airway insertion.
Apnea time: time from last spontaneous breath after propofol administration to
first spontaneous breath
LMA insertion score: Jaw mobility was graded as: 1-fully relaxed, 2-mild
resistance, 3-tight but, opens, 4-close. Coughing/movement were graded as: 1none, 2-one or two coughs, 3-three or more coughs, 4- bucking/movement. In
each category, scores ≤2 were considered optimum for LMA insertion.

Major Variables
Studied and Their
Definitions
Measurement and
Data Analysis

Findings

Results

The sample size was calculated using Statistical Package Software Statistical
Analysis with an alpha error of 0.05, confidence of 95% (infinite population). The
calculated power of the study was 88%. Statistical analysis with Student t-test (ztest) for parametric data. Chi-square test for nonparametric data. P< 0.05 was
considered statistically significant.
Two groups were similar in terms of distribution of age, sex, and weight.
Insertion conditions with respect to jaw mobility, were appropriate in all patients
of Group D. Adverse events to insertion of LMA and hemodynamic variables
were comparable in both the groups. Increase in RR in dexmedetomidine group
compared to fentanyl group.
37 (92.5%) patients of group D and 35 (87.5%) patients of group F had LMA
insertion score of <2 and 5 (12.5%) patients of group F had score >2. Statistically
significant (P < 0.001) increase in the RR in Group D from 5 min after insertion
of LMA which got stabilized at 22/min by 15 min. The duration of apnea was
longer in Group F (290 s) than in Group D (227 s).
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Conclusions

Appraisal: Worth
to Practice/Level

THEME

Dexmedetomidine can be a comparable alternative to fentanyl as an adjuvant to
propofol for providing optimum insertion conditions for LMA and preservation of
respiration. Both drugs provide stable hemodynamic profile but,
dexmedetomidine is superior to fentanyl in preserving respiration.
Strength: Better RR effect with dexmedetomidine than with fentanyl. This study
did not require inhalation gasses.
Limitations: Small study. not included control group that is, propofol alone for
insertion of LMA although unethical due to propofol provides inadequate
insertion. Pain, recovery, and sedation scale were not included anywhere in the
study.
Risk of harm: Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion.
Feasibility of use: Adequate, dexmedetomidine is commercially available and
provides better respiratory status during LMA insertion.
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.

Evaluation Table 3
Citation

Jaya Choudhary, Aaditya Prabhudesai, & Chumki Datta. (2019).
Dexmedetomidine with propofol versus fentanyl with propofol for insertion of
Proseal laryngeal mask airway: A randomized, double-blinded clinical
trial. Journal of Anesthesiology Clinical Pharmacology, 35(3), 368–372.
https://doi-org.ezproxy.fiu.edu/10.4103/joacp.JOACP_104_18

Design/Method

Prospective, randomized, double-blinded, parallel group clinical trial.
Inclusion criteria: American Society of Anesthesiologists (ASA) physical status
I–II patients, aged 18–60 years, weighing between 35 to 80 kg scheduled for
elective urosurgical procedures lasting <120 mins.
Exclusion criteria: anticipated difficult airway, morbid obesity (BMI >35), or
those at risk of gastric aspiration.
Seventy-four American Society of Anesthesiologists (ASA) physical status I–II
patients were randomly allocated to receive either dexmedetomidine 1 µg/kg
[Group PD] or fentanyl 1 µg/kg [Group PF]
Independent variable: IV1 is dexmedetomidine and propofol vs IV2 is fentanyl
and propofol.
Dependent variable: DV1 is apnea time; DV2 is laryngeal mask airway insertion
under the Muzi score; DV3 is bradycardia; DV4 is hypotension; DV5 is
Emergence time; and DV6 is Visual Analogue score (VAS).
Insertion evaluated by a blinded investigator: jaw mobility (1: fully relaxed, 2:
mild resistance, 3: tight but opens, and 4: closed), coughing or movement (1:
none, 2: 1 or 2 coughs, 3: 3 or more coughs, and 4: bucking/ movements). Score
≤2 was considered optimal for PLMA insertion.
Effective ventilation was confirmed by adequate chest rise and a capnograph
trace.
Bradycardia: Heart Rate <60
Hypotension: Systolic Blood Pressure <90 mm Hg.

Sample/Setting

Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis
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Findings

Results

Conclusions

Appraisal: Worth
to Practice/Level

THEME

Emergence time: time between switching off sevoflurane to first response to
verbal commands.
Postoperative pain was assessed in the postoperative anesthesia care unit (PACU)
with the VAS
The categorical variables were compared between the two groups using the
Pearson’s Chi-square test. Continuous variables are expressed as mean ± SD and
compared using unpaired t-test and Mann–Whitney U test. The statistical software
SPSS version 20 was used for the analysis of data. P value <0.05; was considered
as significant.
The two groups were comparable in terms of patient characteristics such as age,
sex, ASA grading, Mallampati grade. In the PF group, PLMA insertion score in
six patients was >2, and in the PD group, three patients had score >2 (Not
significant). Baseline HR, SBP, and MAP were comparable in both the groups.
Incidence of apnea was greater in PF group as compared to PD group. Emergence
time was significantly longer in PD group as compared to PF group.
Postoperative pain in the PACU showed that VAS values were significantly lower
in PD group as compared to PF group
83.8% patients in the group PF and 91.9% in the group PD achieved optimal
insertion condition (not significant). Hemodynamic stability was maintained in
both the groups, but the incidence of apnea was significantly higher in the PF
group (P = 0.011). Apnea time was 68.8±104.1 in the PD ground vs 123.8±67.7 in
the PF group (P = 0.011). Emergence time was prolonged in PD group
412.2±77.6 vs PF group 227.3±66.6 but postoperative pain scores were
significantly lower, 36 in PD group vs 15 in PF group (P < 0.001)
Single IV dose of both dexmedetomidine and fentanyl administered prior to
induction with propofol provide comparable and satisfactory PLMA insertion
conditions and stable hemodynamic parameters.
Dexmedetomidine preserved patient’s spontaneous breathing and provided better
postoperative analgesia.
Strength: Stable hemodynamics, less apnea time and better postoperative control
in PACU with dexmedetomidine. Anesthesia maintenance with inhalation gasses.
Limitations: Small study. Patients excluded after three unsuccessful attempts.
Depth of anesthesia achieved for PLMA insertion in two groups not assessed due
to non-availability of BIS monitor. No control group as propofol alone fails to
provide adequate condition for PLMA insertion and may increase the incidence of
respiratory morbidities.
Risk of harm: Pain monitoring is of great importance to determine patient comfort
during insertion. Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion
Feasibility of use: Adequate, dexmedetomidine is commercially available and
probes to be feasible for insertion, stable hemodynamics
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.

Evaluation Table 4
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Citation

Design/Method

Sample/Setting

Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis

Findings

Results

Gupta S, Gadani HN, Shah PR. A comparative evaluation of use of
dexmedetomidine versus fentanyl for anesthesia induction with propofol for
insertion of laryngeal mask airway. Anesthesia, Pain & Intensive Care.
2018;22(2):165-173. Accessed September 26, 2020.
Prospective, double blind, randomized clinical study
Inclusion criteria: healthy patients of both sexes, having ASA grade I and II, aged
18-70 years, weighing 30-80 kg were selected undergoing elective minor surgical
procedures under general anesthesia
Exclusion criteria: ASA grade III-IV, pregnant patients, smokers, patients
undergoing oral and nasal surgeries, having inadequate mouth opening, patients
with risk of aspiration, poorly controlled hypertension, respiratory compromises,
neuromuscular diseases, hematological disorders and severe hepatic or renal
insufficiency, patients allergic to any of the study drug
140 healthy patients of both sexes, having ASA grade I and II, random numbers
by a person blinded to the procedure into two groups, Group-D
(dexmedetomidine-propofol group) (n = 70) and Group-F (fentanyl-propofol
group) (n = 70).
Independent variable: IV1 is dexmedetomidine and propofol vs IV2 is fentanyl
and propofol.
Dependent variable: DV1 is Baseline parameters; DV2 is Correct LMA
placement; DV3 is bradycardia; DV4 is apnea time; DV5 is LMA insertion
Baseline parameters: HR, RR, SBP, DBP, MAP, SpO at 0, LMA insertion, 1, 3, 5,
10, 15, 30, 45 and 60 mins.
Correct LMA placement was confirmed with the expansion of the chest wall with
bag compression
Bradycardia: Heart rate < 45
Apnea time: time from last spontaneous breath after propofol administration to
first spontaneous breath of the patient was noted.
LMA insertion score by Muzi: Jaw mobility was graded as: 1-fully relaxed, 2mild resistance, 3-tight but, opens, 4-close. Coughing/movement were graded as:
1-none, 2-one or two coughs, 3-three or more coughs, 4- bucking/movement. In
each category, scores ≤2 were considered optimum for LMA insertion.
Data obtained from observations were entered and analyzed in EPI info 7.
Continuous variables were expressed in mean and standard deviation. Categorical
variables were expressed in percentages. t-test and chi square test were applied
accordingly. P value < 0.05 was considered statistically significant and < 0.001
was considered highly significant.
No significant differences in patients’ age, weight, or sexes in the two groups. No
significant differences in baseline heart rates in the two groups (p = 0.20) and on
LMA insertion. SBP had highly significant differences at 1, 3, 5, 10 and 15 mins.
DBP, MAP and RR had highly significant differences at 1, 3, 5, 10 ,15 and 30
mins Breath holding was significantly more in Group-F as compared to Group-D.
No significant change in SpO2 at any time in both the groups. Apnea greater in
Group F
5 patients in Group-D developed bradycardia.
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Differences in systolic blood pressure (mm of Hg) readings were not statistically
significant at baseline (T0), on LMA insertion (TL), and at 30, 45 and 60 min.
Highly significant differences at 1, 3, 5, 10 and 15 mins. (p< 0.001)
Differences in diastolic blood pressure (mmHg), mean blood pressure (mmHg)
and respiratory rates readings were not statistically significant at baseline (T0),
and on 60 min (T60). Significant difference was recorded at T45 (p = 0.006), and
highly significant differences were noted at LMA insertion, 1, 3, 5, 10, 15 and 30
mins. (p< 0.001)
Hypotension was noted in 3 patients of Group-D intra operatively, corrected with
IV fluids.
Apnea was 237.78 ± 21.36 sec vs. 208.74 ± 15.69 sec in Group-F and Group-D (p
= 0.0001; highly significant)
Conclusions

Appraisal: Worth
to Practice/Level

THEME

Dexmedetomidine 1 μg/kg with propofol 2mg/kg IV provides beneficial effect in
attenuation of hemodynamic response to LMA insertion, better preservation of
spontaneous respiration and acceptable LMA insertion conditions as compared to
fentanyl 1 μg/kg with propofol 2mg/kg IV without major side effects.
Strength: beneficial to the consultants with limited availability of opioids, and to
avoid side effects of opioids on patients
Limitations: Small study. control group of propofol alone for insertion of LMA,
unethical given inadequate LMA insertion. Only experienced users inserted LMA.
BIS was not used. Included population limited by exclusion criteria.
Risk of harm: Pain monitoring is of great importance to determine patient comfort
during insertion. Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion.
Feasibility of use: Adequate, dexmedetomidine is commercially available and
probes to be feasible for insertion, better hemodynamics results and less apneic
events
Laryngeal mask airway insertion with dexmedetomidine decreases hemodynamic
instability, ensure spontaneous respirations, and reduces propofol dosage on
induction.

Evaluation table 5
Citation

Shalaka Sandeep Nellore, Abhijeet Dattatray Waychal, Preeti Sachin Rustagi.
Comparison of Dexmedetomidine-Propofol versus Fentanyl-Propofol on Insertion
Conditions of Proseal Laryngeal Mask Airway. Journal of Clinical and Diagnostic
Research. 2016;10(11). doi:10.7860/JCDR/2016/23244.8934

Design/Method

Prospective randomized double-blind study
Inclusion criteria: ASA I and II patients of either sex scheduled for short surgical
procedures under general anesthesia.
Exclusion criteria: neck and facial burns, reduced mouth opening, BMI>30, on Bblocker therapy, basal heart rate <60 and known egg allergy
60 ASA I and II patients of either sex scheduled for short surgical procedures
under general anesthesia. Recruited in 6 different blocks as follows: FFDD,
FDFD, FDDF, DFF, DFDF, DDFF

Sample/Setting
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Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis

Findings
Results

Conclusions

Appraisal: Worth
to Practice/Level

THEME

Independent variable: IV1 is dexmedetomidine and propofol vs IV2 is fentanyl
and propofol
Dependent variable: DV1 is PLMA insertion, DV2 is hemodynamic parameters;
DV3 is apnea time.
Premedication with glycopyrrolate.
PLMA insertion conditions assessed jaw relaxation by “Young’s criteria” and
swallowing, gagging, coughing, head or limb movements, lacrimation,
laryngospasm etc., according to “Modified Scheme of Lund and Stovener
Hemodynamics parameters during PLMA insertion were also noted at intervals of
baseline, 1, 3, 5, 10, 15 and 20 minutes
Apnea time < 30 seconds.
Mean and standard deviation for all the values were calculated and compared
between two groups D and F. The demographic data was analyzed using Mann
Whitney-test and Fisher-exact test. Ordinal categorical data such as PLMA
insertion conditions and number of attempts were analyzed by Fisher-exact, or
Chi-square test and hemodynamic parameters were analyzed using the unpaired ttest or Mann-Whitney test. A p-value <0.05 was accepted as statistically
significant.
Induction dose and increments of propofol required in group D was significantly
lower (p<0.001),
Age (p=0.23), gender (p= 0.99), height (p=0.66), weight (p=0.68), and BMI
(p=0.39), both the groups were comparable. Modified Mallampati Test which was
comparable (p=0.36), the groups D and F. Apnea, more than 30 seconds, after
induction occurred in both groups and was comparable.
Jaw relaxation by Young’s criteria was comparable (p=0.41), between the two
groups.
The “Modified scheme of Lund and Stovener” were also comparable and
statistically not significant (p=0.12), between groups D and F.
Hemodynamically, heart rate variation and mean arterial pressure were not
statistically significant between two groups.
Dexmedetomidine and fentanyl when both used individually for co-induction with
propofol for PLMA insertion give excellent overall insertion conditions with
hemodynamic stability. Dexmedetomidine also significantly reduces the
requirements of induction dose propofol for PLMA insertion
Strength: Pre induction assessment with Mallampati test.
Limitations: Small study. Premedication with glycopyrrolate. PLMA insertion
conditions may be assessed more accurately by the effect-site concentration of
propofol using target-controlled infusion. No BIS uses. BMI > 30 not included.
Risk of harm: Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion
Feasibility of use:
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.
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Evaluation Table 6
Citation

Uzümcügil F, Canbay O, Celebi N, Karagoz AH, Ozgen S. Comparison of
dexmedetomidine-propofol vs. fentanyl-propofol for laryngeal mask
insertion. Eur J Anaesthesiol. 2008;25(8):675-680.
doi:10.1017/S0265021508004213

Design/Method

Prospective randomized study
Inclusion criteria: ASA physical status I–II, scheduled to have minor urological
procedures, were randomized into two groups.
Exclusion criteria: gastroesophageal reflux, allergy, or sensitivity to volatile
anesthetics or propofol, asthma, dysrhythmia, congestive heart failure and any
pathology of CNS and respiratory tract
52 patients, aged 26–65 years, ASA physical status I–II, scheduled to have minor
urological procedures, were randomized into two groups.
Independent variable: IV1 is dexmedetomidine and propofol vs IV2 is fentanyl
and propofol
Dependent variable: DV1 is LMA insertion, DV2 is hemodynamic parameters;
DV3 is apnea time; and DV4 is emergence time
LM insertion: Scoring system, modified from Muzi. jaw mobility (1: fully
relaxed, 2: mild resistance, 3: tight but opens, 4: closed), coughing or movement
(1: none, 2: one or two coughs, 3: three or more coughs, 4: bucking/ movement)
Category scores <2 was defined as acceptable for LM insertion
Apnea time: last spontaneous breath after propofol administration to the first
spontaneous breath
Hemodynamic parameter: BP and HR before insertion of LM, 1 min, 3 min and 5
min
Bradycardia: Heart Rate <45
Emergence time: time needed for the patients to respond to verbal stimulus

Sample/Setting
Major Variables
Studied and Their
Definitions
Measurement and
Data Analysis

Findings

Data analysis was performed using SPSS. Data were shown as mean 6 SD or
median(range) for continuous variables, where appropriate. Categorical variables
were presented as percentages. Means were compared using Student’s t-test or the
U-test. hemodynamic parameters were evaluated using Repeated Measures
ANOVA or Friedman test. When the P value from the Variance Analysis and
Friedman test statistics were statistically significant, multiple comparison tests
were used to determine which measurement differed from the others. The
Bonferroni correction was applied for comparisons of repeated measures between
groups. For categorical comparisons x 2 -test or Fisher’s exact test were used,
where appropriate. P, 0.05 was considered statistically significant.
Apnea was greater in Group F (24 patients) than in Group D (11 patients) (P,
0.01).
Group D, the respiratory rates increased compared to the baseline. In Group D,
the HRs at different time intervals were similar but significantly different from
the baseline immediately before LM insertion. The emergence time was greater in
Group D.
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Results

Conclusions

Appraisal: Worth
to Practice/Level

THEME

Two groups were similar in terms of gender distribution, age, weight and
durations of surgical procedures.
Baseline systolic BP (SBP) and mean BP (MBP) were similar.
The emergence time was 81–385 s (mean: 253.5 s) in Group F and 85–992 s
(mean: 397.5 s) in Group D (P , 0.001).
Dexmedetomidine, when used before propofol induction, provides successful
laryngeal mask insertion comparable to fentanyl, while preserving respiratory
functions more than fentanyl.
Strength: Study is complete evaluated multiple independent parameters
Limitations: Small study. Not include a control group in which propofol was used
alone, felt to be unethical. BIS monitor not use. The baseline respiratory rates
were not similar statistically
Risk of harm: Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion
Feasibility of use:
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.

Evaluation Table 7
Citation

Design/Method

Sample/Setting

Major Variables
Studied and Their
Definitions
Measurement and
Data Analysis

Surabhi A. Lande, C. P. Gadkari, A. R. Bhure, Sobhan Aich. “Comparison of
Dexmedetomidine Propofol Virus Fentanyl – Propofol for Conditions of
Laryngeal Mask Airway Insertion in Elective Surgeries”. Journal of Evolution of
Medical and Dental Sciences 2014; Vol. 3, Issue 15, April 14; Page: 4042-4051,
DOI: 10.14260/jemds/2014/2397
Prospective, randomized, double blind comparative study.
Inclusion criteria: ASA I-II category, MPC grade I and II who were scheduled for
short elective surgeries.
Exclusion criteria: asthma, respiratory or oropharyngeal tract pathology or those
on anti-hypertensive drugs like β-blockers and calcium channel blockers, patients
with risk of aspiration like full stomach, hiatus hernia, pregnancy, patients with
known drug allergy
60 patients aged between 20 and 50 years with an ASA I-II category, MPC grade
I and II who were scheduled for short elective surgeries.
Random sequence was generated by random allocation software. Utilizing the
value of change in MBP from the study of Uzümcügil. F et al and keeping
confidence interval of 95% and power of the test 80%, the sample size was
calculated using Epi info software to be 60 i.e., 30 patients in each group.
Observer and patients were unaware of the study drug
Independent variable: IV1 is dexmedetomidine vs IV2 is fentanyl
Dependent variable: DV1 is hemodynamic responses, DV2 is bradycardia, DV3 is
LMA insertion.
Hemodynamic responses: heart rate (HR), blood pressure (BP), respiratory rate
(RR) at baseline, just after administering the study drug (Pre-med), immediately
before LMA insertion, 30 s, 1min, 2mins, 3mins, 5mins, 7mins, 10min after LMA
insertion
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Bradycardia: heart rate < 15% of the baseline or < 50/mins
LMA insertion: scored by the, modified from Muzi.

Findings

Results

Conclusions
Appraisal: Worth
to Practice/Level

THEME

No Data Analysis specified, except for statistically significant p < 0.05.
Better jaw relaxation in dexmedetomidine group compared to fentanyl group
A statistically significant fall (p value < 0.05) in mean SBP was seen in the Post
LMA, 1 min, 2 mins, 3mins compared to the Pre LMA mean SBP in
dexmedetomidine group.
In fentanyl group statistically significant rise (p value = 0.003) in mean SBP was
seen in Post LMA phase compared to the Pre LMA mean SBP
1 patient (3.33%) required two attempts at LMA insertion in dexmedetomidine
group and 5 patients (16.67%) in fentanyl group required two attempts at LMA
insertion. This difference was not statistically significant. (p value = 0.08)
No statistically significant difference (p value > 0.05) between the mean DBP or
RR of the dexmedetomidine and fentanyl group throughout the study duration
Dexmedetomidine gives better insertion conditions and better attenuation of
pressor response to LMA insertion compared to fentanyl in the given doses
Strength: Study focus on hemodynamics and insertion
Limitations: Small study. Premedicated with Ranitidine, Ondansetron,
Midazolam and Glycopyrrolate. Lignocaine use in addition to Propofol.
Risk of harm: Lack of use of inhalation gasses might not provide continuous
sedation and greater risk of awareness given dexmedetomidine was only given for
insertion
Feasibility of use:
Laryngeal mask airway insertion with dexmedetomidine decrease hemodynamic
instability, ensure spontaneous respirations, and reduce propofol dosage on
induction.

Evaluation Table 8
Citation

Sintavanuruk K, Pongruekdee S, Thaharavanich R, Laosuwan S, Charuluxananan
S.Comparative study of effective-site target controlled infusion with standard
bolus
induction of propofol for laryngeal mask airway insertion. ASIAN
BIOMEDICINE. 4(1):177-182. Accessed October 24,
2020.http://search.ebscohost.com.ezproxy.fiu.edu/login.aspx?direct=true&db=eds
ws&AN=000276053900022&site=eds-live

Design/Method

Randomized, prospective, single-blinded, clinical study was used for this study.
This study compares the efficacy of induction of anesthesia with propofol for
LMA insertion between the effective-site target-controlled infusion (TCI) of
propofol, using 6 μg/mL, and the standard bolus propofol dose of 2.5 mg/kg in
elective surgical patients.

Sample/Setting

Seventy-eight unpremedicated patients, American Society of Anesthesiologists
(ASA) physical status I and II undergoing elective surgical procedure were
randomly allocated between two groups. Group 1 received the standard bolus
propofol dose of 2.5 mg/kg. Group 2 received effective site TCI (Schnider model)
dose of 6 μg/mL for LMA
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insertion. The hemodynamics and anesthetic depth (Bispectral index score) were
monitored and recorded during and immediately after LMA insertion. The
number of insertions attempted, insertion quality score, induction time, and
propofol doses used were recorded and compared between groups
Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis

Findings

Results

Independent variable: IV1 is propofol 2.5 mg/kg vs site target concentration of 6
μg/mL by propofol TCI
Dependent variable: DV1 BIS monitor; DV2 hypotension; DV3 Hypoxemia;
DV4 insertion quality score
hypotension (decrease blood pressure to more than 30% from baseline) or
hypoxemia (SpO2 <90%) in the present study.
insertion quality score
Score 1 = full mouth opening and no movement,
Score 2 = partially mouth opening, slight gagging,
and fingers movement,
Score 3 = difficult mouth opening, coughing and
gross limbs movement.
The Pearson’s Chi-Square test was used for comparison of gender, LMA insertion
attempt, and insertion quality between groups. A p-value less than 0.05 was
considered as significant.
BIS scores were significantly lower in the bolus group than the TCI group during
post LMA insertion period.
The bolus group showed significantly higher propofol doses for induction than the
TCI group.
The TCI group took significantly longer induction time than the bolus group.
In 28 patients of the bolus group and 30 patients of the TCI group, LMA were
inserted with the insertion quality score of 1.
The success rate of the first insertion attempt was equal in both groups (92.3%).
There was no significant hemodynamic response difference between the groups
during pre-induction, induction, insertion, and post insertion
period. The BIS score was significantly lower during post insertion period in
group 1 (51.4+11.0) than group 2 (58.4+3.2) (p=0.013). The propofol doses in
group 2 were significantly lower than in group 1 (110.6+14.8 vs. 153.5+21.5) (p
<0.001). Patients in group 2 required significantly more induction time than group
1 (146.9+42.3 vs. 103.4+33.6 (p <0.001).

Conclusions

Propofol induction with TCI provided equal success rate as compared with
standard bolus propofol induction for LMA insertion and insertion quality score.
TCI significantly lowered the propofol consumption when compared with the
standard 2.5 mg/kg propofol dose.

Appraisal: Worth
to Practice/Level

Strength:
Limitations: Small study.
Risk of harm:
Feasibility of use: adequate, since BIS monitoring is affordable and available at
many clinical sites
Bolus of propofol (2.5 mg/kg) is associated with higher induction doses

THEME
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Evaluation Table 9
Citation
Tan AS, Wang CY, Tan ASB, Wang CY. Fentanyl dose for the insertion of
Classic Laryngeal Mask Airways in non-paralyzed patients induced with propofol
2.5 mg/kg. Anesthesia & Intensive Care. 2010;38(1):65-69.
doi:10.1177/0310057x1003800112
Design/Method

Sample/Setting

Major Variables
Studied and Their
Definitions

Measurement and
Data Analysis

Findings

Results

Conclusions

Appraisal: Worth
to Practice/Level

THEME

Randomized, controlled trial was to determine the optimum dose of fentanyl in
combination with propofol 2.5 mg.kg-1 when inserting the Classic™ Laryngeal
Mask Airway.
Seventy-five ASA I or II patients were randomly assigned to five groups of
fentanyl dosage: 0 μg.kg-1 (placebo), 0.5 μg.kg-1, 1.0 μg.kg-1, 1.5 μg.kg-1 and
2.0 μg.kg-1. Anesthesia was induced by first injecting the study drug over 10
seconds. Three minutes after the study drug was injected, propofol (2.5 mg.kg-1)
was injected over 10 seconds.
Independent variable: IV1 is dexmedetomidine and propofol 2.5mg/kg vs IV2 is
fentanyl and propofol.
Dependent variable: DV1 SBP; DV2 is Correct LMA placement; DV3 is
bradycardia; DV4 is apnea time; DV5 is LMA insertion conditions
apnea (>5 minutes)
hypotension (systolic blood pressure <80 mmHg) and bradycardia (heart rate <50
bpm)
An optimal score for insertion was calculated by adding the grades for all the
insertion condition categories of 1, 2 or 3. A total score of 6 would be considered
optimal
The chi-square test for trends ‘linear association’ was used to compare insertion
conditions with respect to increasing dosage.
Higher doses of fentanyl are associated with high incidence of apnea.
The study found a significantly high incidence of apnea occurred mainly in the 2
μg.kg-1 group.
This study found that there was a high rate of successful first attempt at insertion
with 1 μg.kg and 1.5 μg.kg, 93% and 87% respectively, compared to 87% in the
2.0 μg.kg-1 group. The 1.0 μg.kg-1 group also achieved an 80% optimal insertion
conditions score of 4, compared to 73% in the 1.5 μg.kg-1 group and 80% in the 2
μg.kg- group.
The study recommends 1.0 μg.kg as the optimal dose of fentanyl when used in
addition to propofol 2.5 mg/kg for the insertion of the Classic™ Laryngeal Mask
Airway.
Strength: There were no instances of severe hypotension or bradycardia with any
of the doses of fentanyl.
Limitations: Small study.
Risk of harm: none
Feasibility of use:
Higher doses of fentanyl (1.5 mcg/kg) are associated with prolonged apnea
episodes.
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Evaluation Table 10
Citation

Rustagi P, Nellore S, Kudalkar A, Sawant R. Comparative evaluation of i-gel[R]
insertion
conditions using dexmedetomidine-propofol versus fentanyl-propofol – A 57
randomized double-blind study. Indian Journal of Anesthesia. 2019;(11). Accessed
October 22,
2020.http://search.ebscohost.com.ezproxy.fiu.edu/login.aspx?direct=true&db=edsgh
w&AN=
edsgcl.606693001&site=eds-live

Design/Method

Randomized controlled double-blinded study. The study aimed to compare
i-gel[R] insertion conditions with propofol induction after pre-treatment with
dexmedetomidine or fentanyl.

Sample/Setting

Eighty ASAI/II patients undergoing general anesthesia were 57 randomized into
Groups D (n = 40) and F (n = 40). Group D received 1. μg/kg dexmedetomidine
over 10 minutes followed by 5ml of 0.9%normal saline (NS) over 2 minutes. Group
F received 10 ml of 0.9%NS over 10 minutes followed by fentanyl 1. μg/kg over 2
minutes. Thirty seconds after study drugs, propofol 2 mg/kg was given. Ninety
seconds after propofol, i-gel[R]was inserted

Major Variables
Studied and
Their
Definitions

Independent variable: IV1 is 1. μg/kg dexmedetomidine propofol 2 mg/kg and vs
IV2 fentanyl 1. μg/kg and propofol 2 mg/kg.

Measurement
and Data
Analysis

Findings

Dependent variable: DV1HR; DV2 MAP; DV3 apnea; DV4 is RR, DV5 jaw
relaxation
Insertion conditions were comparable between both groups. Moderately relaxed jaw,
coughing and movement was observed in more patients of Group F.
Bradypnea (respiratory rate <12/min)
Apnea (cessation of respiration >30 seconds)
‘Young’s Criteria was used to measure jaw relaxation: ‘Absolutely relaxed jaw-I,
moderately relaxed jaw-II, poorly relaxed jaw-III
The overall i-gelÂ® insertion conditions were assessed using the Modified Scheme
of Lund and Stovener: [Excellent- No gagging or coughing, no laryngospasm, no
patient movement, Good- Mild to moderate gagging or coughing, no laryngospasm,
mild to moderate patient movement, Poor- Moderate to severe gagging or coughing,
no laryngospasm, moderate to severe patient movement, Unacceptable- Severe
gagging or coughing, laryngospasm,
severe patient movement. If any of the above were present during the first attempt of
the i-gelÂ® insertion, then a further bolus of 0.5 mg/kg of propofol was
administered.
‘Young’s Criteria was used to measure jaw relaxation: ‘Absolutely relaxed jaw-I,
moderately relaxed jaw-II, poorly relaxed jaw-III
Data was analyzed using SPSS ver. 16.0 software
This study findings are in accordance with a study by Lande SA et al who compared
dexmedetomidine and fentanyl for LMA insertion and reported 96.6% patients
having relaxed jaw with dexmedetomidine.
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MAP after propofol induction was significantly lower in group F than group D.
Propofol when used for induction in a dose of 2.0-2.5 mg/kg decreases mean blood
pressure due to its vasodilatory and myocardial depressing effects which can be
further potentiated by co-induction with fentanyl.
Pre-administration of dexmedetomidine in the dose of 1. μg/kg also reduces the
frequency of hypotensive episodes before and after i-gelÂ® insertion. A greater
percentage decrease from baseline in heart rate with dexmedetomidine was
recorded.
Dexmedetomidine in a dose of 1. μg/kg is previously reported to blunt the
sympatho-adrenal responses to i-gelÂ® insertion while fentanyl 1. μg/kg did not
suppress sympatho-adrenal response to LMA insertion adequately.
In the present study, the incidence and mean duration of apnea was significantly
more with fentanyl (P < 0.01) than with dexmedetomidine. Higher incidence of
apnea could also be due to more additional boluses of propofol required in the
fentanyl group.
Results

Five out of forty patients in Group F and 1/40 in Group D (P = 0.08) had a
moderately relaxed jaw during i-gelÂ® insertion. None of the patients had a poorly
relaxed jaw. However, group F had more episodes of coughing and movement
during i-gelÂ® insertion necessitating additional propofol boluses. No
laryngospasm or bronchospasm was observed. Total dose of propofol was
significantly (P =0.02) higher with fentanyl (2.21 + 0.39 mg/kg) than with
dexmedetomidine (2.07 + 0.21 mg/kg).

Conclusions

Dexmedetomidine and fentanyl provide comparable conditions for i-gelÂ®
insertion with propofol.
Strength: Reduce the dose of propofol and associated adverse effects
Limitations: depth of anesthesia at the time of i-gelÂ® insertion was only assessed
clinically and no specific monitor was used due to non-availability.
Risk of harm: The reduction in MAP after fentanyl-propofol was well tolerated by
pre-hydrated, ASA I-II patients in this study however precaution is needed in
elderly/debilitated patients.
Feasibility of use:
Feasibility of use: Adequate, dexmedetomidine is commercially available and
probes to be feasible for insertion, better hemodynamics results and less apneic
events
Reduce propofol dose requirement for induction.
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Evaluation Table 11

Citation

Design/Method

Yoo J, Kwak H, Kim Y, Park C, Lee S, Kim J. The effect of dexmedetomidine
pretreatment on the median effective bolus dose of propofol for facilitating
laryngeal mask airway insertion. Journal of Anesthesia. 2017;31(1):11-17.
doi:10.1007/s00540-016-2245-7
Blind RCT of 40 patients, aged 19–60 years with ASA physical status I–II, and
scheduled to undergo elective minor surgery in which the use of LMA was
indicated
were included. The study Investigates the effect of dexmedetomidine (1 μg/kg)
pretreatment on the median effective dose (ED50) of propofol for facilitating
successful laryngeal mask airway (LMA) insertion compared
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to propofol alone.
Forty patients were randomized to either the control group (n = 21) or the
dexmedetomidine group (n = 19). After infusion of normal saline or
dexmedetomidine
1 μg/kg over 10 min, 1 % lidocaine 0.5 mg/kg, followed by propofol 2.5 mg/kg
was administered and the laryngeal mask airway was inserted without muscle
relaxants.
The ED50 of propofol for successful LMA insertion was determined by the
modified Dixon’s up-and-down method.
Independent variable: IV1 is dexmedetomidine 1 μg/kg pretreatment on the
median effective dose (ED50) of propofol vs propofol alone.
Dependent variable: DV1 mean arterial pressure (MAP) DV2 is heart rate (HR)),
DV3 is BIS values
Hemodynamic and BIS changes were compared by repeated measures ANOVA.
The present study showed that the ED50 of propofol was. 1.9 mg/kg for LMA
insertion with a loading dose of 1 μg/ kg dexmedetomidine over 10 min.
The ED50 of propofol for smooth insertion of the LMA, as determined by the
Dixon’s up-and-down method, was significantly higher in the control group than
in the dexmedetomidine group (3.1 ± 0.4 vs 1.9 ± 0.3 mg/ kg, P < 0.001). The
MAP was higher, and HR was lower in the dexmedetomidine group than in the
control group during drug infusion and LMA insertion. The BIS value was lower
in the dexmedetomidine group during drug infusion. Hypotension developed in 2
patients in the control
group and 1 patient in the dexmedetomidine group.
The bolus dose of propofol needed for successful LMA insertion was 1.9 mg/kg
in 50 % of adults without muscle relaxant after pretreatment with
dexmedetomidine 1 μg/kg. Pretreatment with dexmedetomidine 1 μg/kg could
reduce the propofol requirement by 38 % for facilitating LMA insertion without
prolonged respiratory depression and hemodynamic instability.
Strength: adequate monitoring with electrocardiogram, pulse oximeter,
noninvasive blood pressure, and bispectral index (BIS)
Limitations: Small study.
Risk of harm: No significant decrease in patient BP or HR were reported
Feasibility of use: adequate
Dexmedetomidine decreases propofol requirements

Evaluation table 12
Citation

Design/Method

Sample/Setting

Yao Y, Qian B, Lin Y, Wu W, Ye H, Chen Y. Intranasal dexmedetomidine
premedication reduces minimum alveolar concentration of sevoflurane for
laryngeal mask airway insertion and emergence delirium in children: a
prospective, randomized, double-blind, placebo-controlled trial. Pediatric
Anesthesia. 2015;25(5):492-498. doi:10.1111/pan.12574
Randomized, double-blind, placebo- controlled study to verify the hypothesis that
intranasal dexmedetomidine premedication can reduce the minimum alveolar
concentration of sevoflurane for laryngeal mask airway insertion in children.
Ninety (ASA) physical status I subjects, aged 3–7 years, were randomized to
three equal groups to receive saline (Group S), dexmedetomidine 1 mcg / kg
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Studied and Their
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(Group D1), or dexmedetomidine 2 mcg/kg (Group D2) approximately 45 min
before anesthesia.
The minimum alveolar concentration for laryngeal mask airway insertion
of sevoflurane was determined according to the Dixon’s up-and-down
method.
Independent variable: IV1 is premedication of 0.9% saline vs dexmedetomidine 1
mcg/kg
or dexmedetomidine 2 mcg/ kg
Dependent variable: DV1 is systolic blood pressure (SBP); DV2 is heart rate
(DBP)

Measurement and
Data Analysis

Findings

Results

Conclusions

Emergence delirium was evaluated using the Pediatric Anesthesia
Emergence Delirium (PAED) scale in the post anesthesia care unit (PACU).
Induction quality was assessed by a single attending anesthesiologist using a 4point scale: 1 = crying, needs restraint; 2 = moderate fear and reassured with
difficulty; 3 = slight fear but can be reassured easily; and 4 = asleep or awake but
co-operative, accepting the mask.
The minimum alveolar concentration for laryngeal mask airway insertion of
sevoflurane was determined according to the modified Dixon’s ‘up-and-down’
approach.
Patient’s responses to laryngeal mask airway insertion were classified by
‘movement’ or ‘no movement’. Movement was defined as the presence of
purposeful movement of extremities, coughing, or bucking within 1 min of
laryngeal mask airway insertion. All responses to laryngeal mask airway insertion
were assessed by two nurses who were blinded to the anesthetic concentration.
Dexmedetomidine premedication improves the quality of recovery profile.
Data indicated that dexmedetomidine premedication may improve parent
satisfaction.
intranasal dexmedetomidine premedication of 1 and 2 mcg/_kg resulted in a
reduction
of postoperative delirium (defined as peak PAED score ≥10) from 48.3% in the
control group to 16.7% and 3.3%, respectively.
The study revealed that intranasal dexmedetomidine (1 or 2 mcg/ kg) produces a
dose-dependent reduction in HR and SBP, which may be attributed to a decrease
in central sympathetic tone and an increase in vagal activity. However, only a
modest reduction (within 20% of baseline values) of hemodynamic variables was
observed, and these effects were clinically insignificant; and no intervention was
required.
Dexmedetomidine premedication of 1 and 2 ug was associated
with reduction in sevoflurane from 1.92% to 1.53% and 1.23%, corresponding
to decrease of 20% and 36%, respectively. The peak PAED scores
(Median [IQR]) were 9 [8–11.5], 5 [3–5.3], and 3 [2–4] in Group S, Group
D1,and Group D2, respectively. No subject cried, required restraint, or
complained of discomfort with intranasal dexmedetomidine
administration in our study.
Intranasal dexmedetomidine premedication produces a dose-dependent
decrease in the minimum alveolar concentration for laryngeal
mask airway insertion of sevoflurane and emergence delirium in the PACU.
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Strength: fix dose of dexmedetomidine 100mcg/ ml (total final volume of
administered was 0.02 ml/ kg) along with standard monitoring, including
electrocardiogram, noninvasive blood pressure, pulse oximetry, and rectal
temperature, was used in all children. Body temperature was maintained at 36.8 _
0.4°C using a Bair Huger. Inhaled and exhaled concentrations of sevoflurane and
end-tidal carbon dioxide partial pressure (PETCO2) were continuously monitored.
Limitations: Subjects with potentially difficult airway, reactive airway
malformation, any sign of upper respiratory infection, or asthma were excluded.
There are no pharmacokinetic data available following administration of
intranasal dexmedetomidine in children. Preliminary results indicated no subjects
need rescue analgesics and all subjects were expected to experience a similar
slight pain in this study, and no evaluation was made on the degree of
postoperative pain, which is likely to affect the incidence of agitation. Lastly,
glucose levels were not monitored, Ghimire et al. (24) reported that
dexmedetomidine decreased plasma insulin concentration and may cause
hyperglycemia in healthy fasting individuals.
Therefore, further studies are required to address these limitations and verify
further findings.
Intranasal Dexmedetomidine produces a dose depend on decrease in the minimum
alveolar concentration
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Joshi GP, Kamali A, Meng J, Rosero E, Gasanova I. Effects of fentanyl
administration before induction of anesthesia and placement of the Laryngeal
Mask Airway: a randomized, placebo-controlled trial. Journal of Clinical
Anesthesia. 2014;26(2):136-142. doi:10.1016/j.jclinane.2013.09.008
Randomized, double-blinded, controlled trial. Assess the effects of fentanyl
administered before induction of anesthesia on movement and airway responses
during desflurane anesthesia via the Laryngeal Mask Airway (LMA).
100 adults, ASA physical status 1, 2, and 3 patients undergoing ambulatory
surgery. Patients were administered fentanyl 1 μg/kg (n=51) or saline (n=49) 3 to
5 minutes
before induction with propofol 2-2.5 mg/kg intravenously (IV), followed by LMA
placement.
Anesthesia was maintained with desflurane titrated to a bispectral index (BIS) of
50-60 and 50% nitrous oxide in oxygen, and fentanyl 25 μg boluses were titrated
to respiratory rate.
Independent variable: IV1 is fentanyl 1 μg/kg (constituted to 10 mL with saline)
vs 10 mL saline before induction of anesthesia.
Dependent variable: DV1 intraoperative coughing (SBP); DV2 apnea at induction
(DBP); DV3 laryngospasm (MAP); DV4 breath holding.
Chi-square or Fisher’s Exact tests, as appropriate, were performed to assess
differences in frequency of movement, coughing, breath holding, laryngospasm,
and postoperative categorical outcomes between the two study groups.
Cochran-Mantel-Haenszel test was also performed to investigate the effect of the
anesthetic technique on the frequency of movement, apnea, coughing, and
laryngospasm after adjusting for smoking status.
The risk of apnea at induction was almost 50% higher in the fentanyl pretreatment
group than the placebo group.
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Although the difference was not statistically significant (P=0.056), preinduction
fentanyl showed a trend towards reduced risk of coughing.
The fentanyl pretreatment group had a higher frequency of apnea (94% vs 64%;
P=0.0003) and longer duration of manual ventilation (3 [interquartile range
(IQR), 1.5-5] min vs 1 [0-1.5] min; Pb0.0001) at induction. In contrast, the
fentanyl pretreatment group had a lower frequency of movements (16% vs 51%;
P=0.0001). The rates of intraoperative breath holding (6.1% vs 8.5%) and
laryngospasm (2% vs 4.3%) in the two groups were similar. All subjects
experiencing laryngospasm were smokers. Adjusting for smoking status did not
affect the differences noted in apnea, duration of manual ventilation, or
Preinduction fentanyl increased the frequency of apnea at induction and duration
of manual ventilation but reduced the frequency of movements. In addition, it
reduced intraoperative coughing in smokers.
Strengths: A standardized maintenance anesthetic technique was utilized for all
subjects. Heart rate (HR), mean arterial blood pressure (MAP), RR, oxygen
saturation (SpO2), ETCO2, and end-tidal desflurane concentration were recorded
every 15 minutes. All subjects received antiemetic prophylaxis with
dexamethasone 4 mg IV after induction of anesthesia and ondansetron 4 mg IV
approximately 20 to 30 minutes before the end of surgery.
Limitations: The use of lidocaine during induction of anesthesia could have
influenced the frequency of movement and respiratory events; however, its use to
reduce pain during injection of propofol has become a standard of care, and both
the groups received lidocaine. It is also possible that the anti-inflammatory and
analgesic efficacy of dexamethasone may have contributed to the reduced airway
reflexes, particularly at the time of LMA removal.
Con-induction with Fentanyl increases the frequency of apnea
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Citation
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Dwivedi MB, Dwivedi S, Singh H, Nagrale M. What happens to the
hemodynamic responses for laryngeal mask airway insertion when we supplement
propofol with butorphanol or fentanyl for induction of anesthesia: A comparative
assessment and critical review. International Journal of Critical Illness & Injury
Science. 2016;6(1):40-44. doi:10.4103/2229-5151.177369
RCT study. Comparison of hemodynamic response of LMA using either
butorphanol or fentanyl in combination with propofol. The combination of
propofol and butorphanol was compared with the combination of propofol and
fentanyl for hemodynamic responses to LMA insertion.
Hundred patients of ASA I and ASA II with Mallampati‑II and III between the
age of 18–60 years who were randomly selected and divided into two groups of
50 each, i.e., Group F (propofol and fentanyl) and Group B (propofol and
butorphanol). Age <18 years and more 60 years, ASA III and IV, Mallampati‑III
and IV. One minute after giving intravenous (IV) opioids, induction was
achieved with IV propofol 2.5 mg/kg. Depth of anesthesia was assessed,
and LMA was inserted.
Independent variable: IV1 is fentanyl and propofol vs IV2 propofol and
butorphanol
Dependent variable: DV1 is systolic blood pressure (SBP); DV2 is diastolic blood
pressure (DBP); DV3 is mean arterial pressure (MAP); DV4 is respiratory rate
(RR); DV5 is SpO2; and DV6 is insertion condition.
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Continuous variables: age, weight, heart rate, systolic blood pressure, diastolic
blood pressure, mean blood pressure and apnea time.
Compiled, and statistically analyzed by computer software package “SPSS
version 14.0.
Significant decreases in the mean arterial pressure in the propofol group over the
first 5 min of induction were found.
The values of mean SBP, DBP, and MBP in our study were lowest at 5 min of
insertion of LMA with statistically significant decrease in Group F than in Group
B.
After insertion of LMA, statistically significant drop-in mean heart rate, systolic
blood pressure (BP), diastolic BP, and mean BP was noted in Group F as
compared to Group B (P < 0.05).
Co-induction agent with propofol 2.5 mg/kg, butorphanol 30 μg/kg is a better
alternative to fentanyl 1.5 mg/kg as far as hemodynamic stability is concerned.
Bradycardia caused by propofol is taken care of by the release of catecholamines
due to butorphanol leading to stable hemodynamics.
Strength: All patients were preoxygenated with 100% O2 for 3 min before
induction. All baseline hemodynamic variables including heart rate (HR), SBP,
DBP, and MBP were comparable before premedication Limitations: Small study.
Risk of harm: Incidence of hypotension, hypertension, or dysrhythmias was
noted. These changes could affect a certain patient population.
Feasibility of use: adequate since adequate monitoring was available.
Butorphanol a synthetic, nonnarcotic analgesic was preferred over fentanyl
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Citation
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Akanksha Dutt, Anjum Khan Joad, Mamta Sharma. Induction for classic
laryngeal mask airway insertion: Does low-dose fentanyl work? Journal of
Anaesthesiology Clinical Pharmacology. 2012;28(2):210-213. doi:10.4103/09709185.94877
Randomized double-blind study. Following preoxygenation, ondansetron 0.1
mg/kg IV was
given. The study drug, fentanyl 1 or 2 mcg/kg was given IV over 10 s by an
anesthesiologist blinded to the drug dose. Two minutes after administration of
this, propofol 2.5 mg/kg was injected IV over 1 min.
96 patients were randomly distributed into F1 (fentanyl 1 mcg/kg) and F2
(fentanyl 2 mcg/kg) groups with both groups having a fixed dose of propofol
(2.5mg/kg). The conditions for LMA insertion, hemodynamic profile,
bronchoscopic view, and incidence of sore throat were compared. Patients were
(ASA) grades 1 and 2, between 18 and 60 years of age, undergoing elective
surgery (modified radical mastectomy, mastectomy, or superficial surgery of the
upper limb).
Independent variable: IV1 is fentanyl (1mcg/ kg) and propofol in a fixed dose
(2.5mg/ kg) vs IV2 fentanyl (2mcgkg) and propofol (2.5mg/kg)
Dependent variable: DV1 is systolic blood pressure (SBP); DV2 is mean arterial
pressure (MAP); DV3 is bradycardia
Continuous variables: age, weight, ASA status, airway (Mallampati grade).
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Depth of anesthesia: The jaw thrust was used as an indicator of adequate depth of
anesthesia.
LMA insertion conditions were graded on a three-point scale using six variables –
mouth opening, ease of LMA insertion, swallowing, coughing, patient
movements, and laryngospasm
Sample size was calculated using Medcalc (Medcalc Software, Mariakerke,
Belgium). Statistical analysis was done using chi-square method. Hemodynamic
parameters were analyzed by “t” test.
There was a significant fall in systolic blood pressures and mean arterial pressure
and higher incidence of bradycardia in the group receiving fentanyl 2 mcg/kg.
The patients who received fentanyl 1 mcg/kg remained more hemodynamically
stable compared to those receiving fentanyl 2 mcg/kg in our cancer patient
population.
The results indicate that as the pre-administered dose of fentanyl was increased
from 1 to 2 mcg/ kg, the supplementary doses of propofol required for facilitating
LMA Classic insertion decreased, even though this decrease was not statistically
significant.
Both doses of fentanyl (1 and 2 mcg/kg) provide comparable insertion conditions
for LMA. Fentanyl in the lower dose provides a more stable hemodynamic
profile.
Strength: Optimal ventilation was constantly assessed by adequate chest
expansion, square wave capnography, and stable oxygenation. Following
successful LMA insertion, position of LMA was assessed using fiberoptic
bronchoscope and graded.
Limitations: Small study.
Risk of harm: Significant fall in systolic and mean arterial pressure in F2 group.
Two of these patients needed atropine IV to reverse bradycardia. In patients with
poor hemodynamic profiles (e.g., ASA 3 and 4, patients with history of ischemic
heart disease, patients with valvular heart disease/using beta blockers), where a
tight control of blood pressures and heart rates would be required, the same fall in
pressures could become clinically significant.
Feasibility of use: adequate, since fiberoptic bronchoscope and additional
supportive medications were readily available.
Fentanyl in doses of 2mcg/kg reduces hemodynamic stability.
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July 15, 2021
Emie Dieudonne
3501 Johnson Street
Hollywood, Fl. 33021
IRB Project#: MHS.2021.080
Project Title: “Improve Knowledge in Utilizing Dexmedetomidine and Propofol for Laryngeal Mask Airway
Insertion: A Quality Improvement Project”
Submission Type: Non-Human Subject Research Determination (Reference# 007426)
Dear Investigator:
The Memorial Healthcare System Institutional Review Board (IRB) has reviewed the proposed activity referenced
above and determined that it does not meet the definition of research with human subjects as outlined in 45
CFR 46.102 or 21 CFR 56.102. Therefore, IRB oversight is not necessary. Please note that you are still required to
follow all applicable institutional policies and ethical guidelines. Additional details regarding this determination
are provided starting on page 2 of this letter. Please review each page carefully.
Sincerely,

Luke Fiedorowicz, Ph.D.
IRB Director
Memorial Healthcare System
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Appendix D

Pretest and Posttest Questionnaire:
The effect of Dexmedetomidine and Propofol for Facilitating Laryngeal Mask Insertion
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of CRNAs pertaining to the use of
dexmedetomidine and propofol combination during LMA insertion
Please answer the question below to the best of your ability. The questions are meant to measure
knowledge and perceptions on the efficacy of Dexmedetomidine- Propofol versus Fentanyl- Propofol
combination for laryngeal mask insertion.
PERSONAL INFORMATION
1. Gender: Male

Female

Other________

2. Age: ______
3. Ethnicity:
Hispanic

Caucasian

African American

Asian

Other

4. Position/Title: _________________________________
5. Level of Education: Associates Bachelors

Masters

DNP/PhD/MD

_____
6. How many years have you been an anesthesia provider?
Over 10

5-10 years

2-5 years
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QUESTIONNAIRE
1. Select which statement is TRUE about dexmedetomidine
a. Dexmedetomidine action on the locus ceruleus preserves hypercapnic ventilatory drive, and
this effect gives the appearance of a natural sleep
b. The respiratory effect of dexmedetomidine is because one of its actions on mu2 receptors in
the central nervous system
c. Dexmedetomidine is considered an opioid agonist
d. Commonly reported side effects include respiratory depression and miosis.
CORRECT ANSWER: A
2. In which receptor does dexmedetomidine exert its action
a. G- protein-coupled receptors
b. α2-receptors
c. Kappa receptor
d. Delta receptor
CORRECT ANSWER: B
3. What are the MOST common side effects of fentanyl?
a. Respiratory depression, nausea, and vomiting
b. Respiratory depression, bradycardia, vomiting
c. Bradycardia, hypotension, and headache
d. Tachycardia, hypertension, headache.
CORRECT ANSWER: A
4. What is the MOST common side effect of dexmedetomidine?
a. Hypotension
b. Hypertension
c. Respiratory depression
d. Tachycardia
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CORRECT ANSWER: A
5. Which dose of dexmedetomidine has been reported to blunt the sympatho-adrenal
responses to laryngeal mask insertion?
a. 2 mcg/kg
b. 1mcg/kg
c. 1mg/kg
d. 2mg/kg
CORRECT ANSWER: B
6. How much could dexmedetomidine pretreatment reduce propofol requirements during
LMA insertion?
a. 10%
b. 15%
c. 28%
d. 38%
CORRECT ANSWER: D
7. According to research which of the following combination of induction agents provides the
best insertion conditions without compromising the patient's hemodynamic state?
a. Dexmetomidine1mcg/kg followed by propofol 2.5 mg/kg
b. Fentanyl 1mcg/kg followed by propofol 2 mg/kg
c. Dexmetomidine1mcg/kg followed by propofol 2 mg/kg
d. Fentanyl 1mcg/kg followed by propofol 2.5 mg/kg
CORRECT ANSWER: C
8. Which statements is CORRECT about fentanyl?
a. The incidence of patients having prolonged apnea increases with increasing doses of
fentanyl
b. Fentanyl provides better hemodynamic stability than dexmedetomidine
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c. The use of fentanyl reduces propofol requirements
d. Fentanyl combined with propofol provides the same conditions for LMA insertion than
dexmedetomidine combined with propofol
CORRECT ANSWER: A
9. Which of the following statement is CORRECT about dexmedetomidine?
a. Pretreatment with dexmedetomidine 1mcg/kg could reduce the propofol requirement by
38 % for facilitating LMA insertion without prolonged respiratory depression and
hemodynamic instability.
b. When comparing fentanyl and dexmedetomidine for attenuating sympathetic response to
LMA insertion, dexmedetomidine shows to increase heart rate up to 18% higher than
baseline.
c. Administration of dexmedetomidine before induction of anesthesia can result in a higher
frequency of apnea and the need for manual ventilation.
d. When combined with propofol, dexmedetomidine causes respiratory compromise by
inhibiting the stimulatory effects of carbon dioxide leading to apnea
CORRECT ANSWER: A
10. How much rise in systolic blood pressure can be seen in patients treated with fentanyl
during the Post LMA phase?
a. 68%
b. 15%
c. 20%
d. 40%
CORRECT ANSWER: D
11. How likely are you to use dexmedetomidine as an alternative to fentanyl during LMA
insertion?
a. Most likely
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b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
12. How likely are you to recommend the use of dexmedetomidine over fentanyl during LMA
insertion?
a. Most likely
b. Somewhat likely
c. Somewhat unlikely
d. Most unlikely
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Appendix E: Educational PowerPoint
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